Animal Antibiotics and Antimicrobials Market by Product (Tetracycline, Penicillin, Sulfonamide, Macrolide, Cephalosporin, Lincosamide), Mode of Delivery (Premixes, Oral Solution, Injection), Animal (Food producing & Companion) - Global Forecast to 2026
The global animal antimicrobials and antibiotics market is projected to reach USD 5.6 billion by 2026 from USD 4.7 billion in 2021, at a CAGR of 3.6% from 2021 to 2026. Market growth can largely be attributed to the rising demand for animal-derived food products, increasing incidence of zoonotic diseases, and the implementation of regulations to prevent the spread of animal diseases. Rising animal healthcare spending and the growing demand for pet insurance are further expected to drive the growth of this market. The untapped emerging markets such as China, India, and Brazil and growth in the overall companion animal population are also expected to offer significant growth opportunities to market players in the coming years
However, the limited number of new antibiotics, growing resistance to antimicrobials and antibiotics, and increasing good husbandry and hygiene practices are expected to hinder the growth of this market to a certain extent.
“The Tetracyclines segment accounted for the largest market share in 2020.”
Based on products, the global animal antimicrobials and antibiotics market is segmented into tetracyclines, penicillins, sulfonamides, macrolides, aminoglycosides, lincosamides, fluoroquinolones, cephalosporins, and other antimicrobial and antibiotic products. In 2020, the tetracyclines segment accounted for 48.9% of the global animal antimicrobials and antibiotics market. Tetracyclines exhibit advantages such as the highest potency against pathogenic microorganisms, are well-absorbed, show low toxicity, and are relatively inexpensive compared to other animal antimicrobial and antibiotic products. These advantages contribute to the large share of this product segment. The fluoroquinolones segment is expected to grow at the highest CAGR of 8.0% during the forecast period. Advantages such as higher efficacy at low concentrations, quick penetration through tissues, and the availability of variations in the route of administration result in the higher adoption of fluoroquinolones among end users.
“The Premixes segment accounted for the largest market share in 2020.”
Based on the mode of delivery, the global animal antimicrobials and antibiotics market is segmented into premixes, oral powders, oral solutions, injections, and other modes of delivery. In 2020, the premixes segment accounted for the largest share of 46.3% of the global animal antimicrobials and antibiotics market. The large share of this segment can be attributed to the advantages of premixes, such as simplified mode of administration and lower instability and hygroscopicity of formulations. The injections segment is expected to witness the highest CAGR of 4.9% during the forecast period. Advantages such as immediate delivery of drugs and rapid onset of drug effects are expected to drive growth in this market.
“The food producing animal segment accounted for the largest market share in 2020.”
Based on animal type, the global animal antimicrobials and antibiotics market is categorized into food-producing animals and companion animals. In 2020, the food-producing animals segment accounted for the largest share of around 73.4%. This segment is also expected to register the highest CAGR of 3.9% during the forecast period. The large share of this segment is mainly due to the rising demand for animal-derived food products, increase in animal healthcare expenditure, and greater concerns about zoonotic diseases.
“North America was the largest regional market for animal antibiotics and antimicrobials market in 2020“
The animal antimicrobials and antibiotics market is segmented into five major regions: North America, Europe, Asia Pacific, Latin America, and the Middle East & Africa. In 2020, North America accounted for the largest share of 30.3% of the global animal antimicrobials and antibiotics market. The large share of this region is mainly due to the increase in the region’s animal population, rising demand for animal-derived food products, growth in pet insurance, and rising animal health expenditure compared to other regions.
The Asia Pacific region is projected to grow at the highest CAGR of 5.4% during the forecast period. Factors such as the rapidly increasing animal population and rising demand for animal-derived food products are driving the growth of this market in the APAC.
The break-down of primary participants is as mentioned below:
The report analyzes the animal antimicrobials and antibiotics market and aims at estimating the market size and future growth potential of various market segments, based on by type of product, mode of delivery, animal type, and region.
The report also provides a competitive analysis of the key players operating in this market, along with their company profiles, product offerings, recent developments, and key market strategies.
Reasons to Buy the Report
This report will enrich established firms as well as new entrants/smaller firms to gauge the pulse of the market, which, in turn, would help them garner a greater share of the market. Firms purchasing the report could use one or a combination of the below-mentioned strategies to strengthen their positions in the market.
This report provides insights on:
However, the limited number of new antibiotics, growing resistance to antimicrobials and antibiotics, and increasing good husbandry and hygiene practices are expected to hinder the growth of this market to a certain extent.
“The Tetracyclines segment accounted for the largest market share in 2020.”
Based on products, the global animal antimicrobials and antibiotics market is segmented into tetracyclines, penicillins, sulfonamides, macrolides, aminoglycosides, lincosamides, fluoroquinolones, cephalosporins, and other antimicrobial and antibiotic products. In 2020, the tetracyclines segment accounted for 48.9% of the global animal antimicrobials and antibiotics market. Tetracyclines exhibit advantages such as the highest potency against pathogenic microorganisms, are well-absorbed, show low toxicity, and are relatively inexpensive compared to other animal antimicrobial and antibiotic products. These advantages contribute to the large share of this product segment. The fluoroquinolones segment is expected to grow at the highest CAGR of 8.0% during the forecast period. Advantages such as higher efficacy at low concentrations, quick penetration through tissues, and the availability of variations in the route of administration result in the higher adoption of fluoroquinolones among end users.
“The Premixes segment accounted for the largest market share in 2020.”
Based on the mode of delivery, the global animal antimicrobials and antibiotics market is segmented into premixes, oral powders, oral solutions, injections, and other modes of delivery. In 2020, the premixes segment accounted for the largest share of 46.3% of the global animal antimicrobials and antibiotics market. The large share of this segment can be attributed to the advantages of premixes, such as simplified mode of administration and lower instability and hygroscopicity of formulations. The injections segment is expected to witness the highest CAGR of 4.9% during the forecast period. Advantages such as immediate delivery of drugs and rapid onset of drug effects are expected to drive growth in this market.
“The food producing animal segment accounted for the largest market share in 2020.”
Based on animal type, the global animal antimicrobials and antibiotics market is categorized into food-producing animals and companion animals. In 2020, the food-producing animals segment accounted for the largest share of around 73.4%. This segment is also expected to register the highest CAGR of 3.9% during the forecast period. The large share of this segment is mainly due to the rising demand for animal-derived food products, increase in animal healthcare expenditure, and greater concerns about zoonotic diseases.
“North America was the largest regional market for animal antibiotics and antimicrobials market in 2020“
The animal antimicrobials and antibiotics market is segmented into five major regions: North America, Europe, Asia Pacific, Latin America, and the Middle East & Africa. In 2020, North America accounted for the largest share of 30.3% of the global animal antimicrobials and antibiotics market. The large share of this region is mainly due to the increase in the region’s animal population, rising demand for animal-derived food products, growth in pet insurance, and rising animal health expenditure compared to other regions.
The Asia Pacific region is projected to grow at the highest CAGR of 5.4% during the forecast period. Factors such as the rapidly increasing animal population and rising demand for animal-derived food products are driving the growth of this market in the APAC.
The break-down of primary participants is as mentioned below:
- By Company Type - Tier 1: 40%, Tier 2: 35%, and Tier 3: 25%
- By Designation - C-level: 25%, Director-level: 55%, and Others: 20%
- By Region - North America: 40%, Europe: 25%, Asia Pacific: 20%, Latin America: 10%, and the Middle East & Africa: 5%
The report analyzes the animal antimicrobials and antibiotics market and aims at estimating the market size and future growth potential of various market segments, based on by type of product, mode of delivery, animal type, and region.
The report also provides a competitive analysis of the key players operating in this market, along with their company profiles, product offerings, recent developments, and key market strategies.
Reasons to Buy the Report
This report will enrich established firms as well as new entrants/smaller firms to gauge the pulse of the market, which, in turn, would help them garner a greater share of the market. Firms purchasing the report could use one or a combination of the below-mentioned strategies to strengthen their positions in the market.
This report provides insights on:
- Market Penetration: Comprehensive information on the product portfolios of the top players in the animal antimicrobials and antibiotics market. The report analyzes this market by type of product, mode of delivery, animal type and region.
- Market Development: Comprehensive information on the lucrative emerging markets, by type of product, mode of delivery, animal type, and region.
- Market Diversification: Exhaustive information about the product portfolios, growing geographies, recent developments, and investments in the animal antimicrobials and antibiotics market
- Competitive Assessment: In-depth assessment of market shares, growth strategies, product offerings, and capabilities of the leading players in the animal antimicrobials and antibiotics market.
1 INTRODUCTION
1.1 OBJECTIVES OF THE STUDY
1.2 MARKET DEFINITION
1.2.1 INCLUSIONS AND EXCLUSIONS
1.2.2 MARKETS COVERED
1.2.3 YEARS CONSIDERED FOR THE STUDY
1.3 CURRENCY
TABLE 1 EXCHANGE RATES UTILIZED FOR CONVERSION TO USD
1.4 LIMITATIONS
1.5 STAKEHOLDERS
1.6 SUMMARY OF CHANGES
2 RESEARCH METHODOLOGY
2.1 RESEARCH DATA
FIGURE 1 RESEARCH DESIGN
2.1.1 SECONDARY DATA
2.1.1.1 Key data from secondary sources
2.1.2 PRIMARY DATA
FIGURE 2 PRIMARY SOURCES
2.1.2.1 Key data from primary sources
2.1.2.2 Key industry insights
FIGURE 3 BREAKDOWN OF PRIMARY INTERVIEWS: BY COMPANY TYPE, DESIGNATION, AND REGION
2.2 MARKET SIZE ESTIMATION
FIGURE 4 SUPPLY-SIDE MARKET SIZE ESTIMATION: REVENUE SHARE ANALYSIS
FIGURE 5 REVENUE SHARE ANALYSIS ILLUSTRATION
FIGURE 6 COUNTRY-LEVEL ANALYSIS OF THE ANIMAL ANTIMICROBIALS AND ANTIBIOTICS MARKET
FIGURE 7 CAGR PROJECTIONS: SUPPLY-SIDE ANALYSIS
FIGURE 8 TOP-DOWN APPROACH
2.3 MARKET BREAKDOWN & DATA TRIANGULATION
FIGURE 9 MARKET DATA TRIANGULATION METHODOLOGY
2.4 MARKET SHARE ANALYSIS
2.5 ASSUMPTIONS FOR THE STUDY
3 EXECUTIVE SUMMARY
FIGURE 10 ANIMAL ANTIMICROBIALS AND ANTIBIOTICS MARKET, BY PRODUCT, 2021 VS. 2026 (USD MILLION)
FIGURE 11 ANIMAL ANTIMICROBIALS AND ANTIBIOTICS MARKET, BY MODE OF DELIVERY, 2021 VS. 2026 (USD MILLION)
FIGURE 12 ANIMAL ANTIMICROBIALS AND ANTIBIOTICS MARKET, BY ANIMAL TYPE, 2021 VS. 2026 (USD MILLION)
FIGURE 13 GEOGRAPHICAL SNAPSHOT OF THE GLOBAL ANIMAL ANTIMICROBIALS AND ANTIBIOTICS MARKET
4 PREMIUM INSIGHTS
4.1 ANIMAL ANTIMICROBIALS AND ANTIBIOTICS MARKET OVERVIEW
FIGURE 14 RISING DEMAND FOR ANIMAL-DERIVED FOOD PRODUCTS AND GROWING INCIDENCE OF ZOONOTIC DISEASES TO DRIVE MARKET GROWTH
4.2 ASIA PACIFIC: ANIMAL ANTIMICROBIALS AND ANTIBIOTICS MARKET, BY MODE OF DELIVERY AND COUNTRY (2020)
FIGURE 15 CHINA ACCOUNTED FOR THE LARGEST SHARE OF THE APAC ANIMAL ANTIMICROBIALS AND ANTIBIOTICS MARKET IN 2020
4.3 ANIMAL ANTIMICROBIALS AND ANTIBIOTICS MARKET: GEOGRAPHIC GROWTH OPPORTUNITIES
FIGURE 16 CHINA TO REGISTER THE HIGHEST GROWTH RATE DURING THE FORECAST PERIOD
4.4 REGIONAL MIX: ANIMAL ANTIMICROBIALS AND ANTIBIOTICS MARKET (2021?2026)
FIGURE 17 NORTH AMERICA WILL CONTINUE TO DOMINATE THE ANIMAL ANTIMICROBIALS AND ANTIBIOTICS MARKET IN 2026
4.5 ANIMAL ANTIMICROBIALS AND ANTIBIOTICS MARKET: DEVELOPED VS. DEVELOPING MARKETS
FIGURE 18 DEVELOPING MARKETS TO REGISTER HIGHER GROWTH RATES DURING THE FORECAST PERIOD
5 MARKET OVERVIEW
5.1 INTRODUCTION
5.2 MARKET DYNAMICS
TABLE 2 DRIVERS, RESTRAINTS, OPPORTUNITIES, AND CHALLENGES: IMPACT ANALYSIS
5.2.1 DRIVERS
5.2.1.1 Rising demand for animal-derived food products
TABLE 3 PAST AND PROJECTED TRENDS IN THE CONSUMPTION OF MEAT AND MILK IN DEVELOPED AND DEVELOPING REGIONS
FIGURE 19 ASIA: COUNTRY-LEVEL CONSUMPTION OF ANIMAL-DERIVED FOOD PRODUCTS, 2020 VS. 2030 (THOUSAND METRIC TONS)
FIGURE 20 ASIA: COUNTRY-LEVEL PRODUCTION OF ANIMAL-DERIVED FOOD PRODUCTS, 2020 VS. 2030 (THOUSAND METRIC TONS)
FIGURE 21 ASIA WAS THE HIGHEST CONSUMER OF MEAT AND MILK IN THE WORLD IN 2018
5.2.1.2 Increasing incidence of zoonotic diseases
TABLE 4 ANIMAL DISEASE OUTBREAKS IN ASIA PACIFIC COUNTRIES (2009–2019)
5.2.1.3 Increasing investments from private players
5.2.1.4 Rising demand for pet insurance and growing animal health expenditure
FIGURE 22 NORTH AMERICA: PET HEALTH INSURANCE MARKET, 2014 VS. 2019 (USD MILLION)
5.2.2 RESTRAINTS
5.2.2.1 Limited number of new antibiotics
5.2.2.2 Growing resistance to antimicrobials and antibiotics
5.2.2.3 Routine prophylactic use of antibiotics being replaced by good husbandry, probiotics, and hygiene practices
5.2.3 OPPORTUNITIES
5.2.3.1 Untapped emerging markets
5.2.3.2 Growth in the companion animal population
TABLE 5 US: COMPANION ANIMAL POPULATION (2010–2025)
TABLE 6 UK : COMPANION ANIMAL POPULATION (2010–2025)
TABLE 7 INDIA : COMPANION ANIMAL POPULATION IN (2010–2025)
TABLE 8 SAUDI ARABIA: COMPANION ANIMAL POPULATION (2010–2025)
5.2.4 CHALLENGES
5.2.4.1 Stringent approval process for antimicrobials and antibiotics
6 INDUSTRY INSIGHTS
6.1 INTRODUCTION
6.2 COVID-19 IMPACT ANALYSIS
6.2.1 IMPACT OF COVID-19 ON THE ANIMAL ANTIMICROBIALS AND ANTIBIOTICS MARKET
6.3 INDUSTRY TRENDS
FIGURE 23 GROWING CONSOLIDATION IN THE ANIMAL HEALTH INDUSTRY IS A MAJOR TREND IN THE ANIMAL ANTIMICROBIALS & ANTIBIOTICS MARKET
6.3.1 GROWING CONSOLIDATION IN THE ANIMAL HEALTH INDUSTRY
TABLE 9 SOME MAJOR ACQUISITIONS IN THE ANIMAL HEALTH INDUSTRY
(2017–2019)
6.3.2 GROWING FOCUS ON LIMITING THE USE OF ANTIBIOTICS IN LIVESTOCK ANIMALS
6.3.3 HIGH GROWTH IN EMERGING MARKETS
6.4 REGULATORY ANALYSIS
FIGURE 24 DEVELOPMENT AND APPROVAL PROCESS FOR ANIMAL PHARMACEUTICAL PRODUCTS
6.5 VALUE CHAIN ANALYSIS
FIGURE 25 ANIMAL ANTIMICROBIALS AND ANTIBODY MARKET: VALUE CHAIN ANALYSIS
6.6 ECOSYSTEM MARKET MAP
TABLE 10 ANIMAL ANTIMICROBIALS AND ANTIBIOTICS MARKET: ECOSYSTEM MAPPING
FIGURE 26 ANIMAL ANTIMICROBIALS AND ANTIBIOTICS MARKET: ECOSYSTEM MARKET MAP
6.7 PORTER’S FIVE FORCES ANALYSIS
TABLE 11 ANIMAL ANTIMICROBIALS AND ANTIBIOTICS MARKET: PORTER’S FIVE FORCES ANALYSIS
6.7.1 THREAT FROM NEW ENTRANTS
6.7.2 THREAT FROM SUBSTITUTES
6.7.3 BARGAINING POWER OF SUPPLIERS
6.7.4 BARGAINING POWER OF BUYERS
6.7.5 INTENSITY OF COMPETITIVE RIVALRY
6.8 SUPPLY CHAIN ANALYSIS
FIGURE 27 ANIMAL ANTIMICROBIALS AND ANTIBIOTICS MARKET: SUPPLY CHAIN ANALYSIS
6.9 PATENT ANALYSIS
TABLE 12 LIST OF ANTIBIOTICS AND THEIR PATENT YEARS
6.10 PRICING ANALYSIS
7 ANIMAL ANTIMICROBIALS AND ANTIBIOTICS MARKET, BY PRODUCT
7.1 INTRODUCTION
FIGURE 28 SALES OF ANTIMICROBIAL AGENTS, BY ANTIMICROBIAL CLASS, AS A PERCENTAGE OF THE TOTAL SALES FOR FOOD-PRODUCING SPECIES (IN MG/PCU): AGGREGATED BY 31 EUROPEAN COUNTRIES, 2018
TABLE 13 ANIMAL ANTIMICROBIALS AND ANTIBIOTICS MARKET, BY PRODUCT, 2019–2026 (USD MILLION)
TABLE 14 ANIMAL ANTIMICROBIALS AND ANTIBIOTICS MARKET, BY COUNTRY, 2019–2026 (USD MILLION)
7.2 TETRACYCLINES
7.2.1 REDUCED COST OF TETRACYCLINES IS A KEY FACTOR DRIVING MARKET GROWTH ACROSS THE GLOBE
TABLE 15 TETRACYCLINES OFFERED BY KEY MARKET PLAYERS
FIGURE 29 SALES OF TETRACYCLINES FOR FOOD-PRODUCING ANIMALS IN EUROPEAN COUNTRIES, 2017 VS. 2018 (MG/PCU)
TABLE 16 TETRACYCLINES MARKET, BY COUNTRY, 2019–2026 (USD MILLION)
7.3 PENICILLINS
7.3.1 RISING INCIDENCE OF ZOONOTIC DISEASES IN LIVESTOCK ANIMALS TO DRIVE THE DEMAND FOR PENICILLINS
TABLE 17 PENICILLINS OFFERED BY KEY MARKET PLAYERS
FIGURE 30 SALES OF PENICILLINS FOR FOOD-PRODUCING ANIMALS IN EUROPEAN COUNTRIES, 2017 VS. 2018 (MG/PCU)
TABLE 18 PENICILLINS MARKET, BY COUNTRY, 2019–2026 (USD MILLION)
7.4 SULFONAMIDES
7.4.1 REDUCED COST AND MULTIPLE APPLICATIONS IN LIVESTOCK INFECTIONS TO DRIVE THE DEMAND FOR SULFONAMIDES IN RURAL REGIONS
TABLE 19 SULFONAMIDES OFFERED BY KEY MARKET PLAYERS
FIGURE 31 SALES OF SULFONAMIDES FOR FOOD-PRODUCING ANIMALS IN EUROPEAN COUNTRIES, 2017 VS. 2018 (MG/PCU)
TABLE 20 SULFONAMIDES MARKET, BY COUNTRY, 2019–2026 (USD MILLION)
7.5 MACROLIDES
7.5.1 INCREASING PRODUCTION OF CATTLE-DERIVED FOOD PRODUCTS TO BOOST THE DEMAND FOR MACROLIDES
TABLE 21 MACROLIDES OFFERED BY KEY MARKET PLAYERS
FIGURE 32 SALES OF MACROLIDES FOR FOOD-PRODUCING ANIMALS IN EUROPEAN COUNTRIES, 2017 VS. 2018 (MG/PCU)
TABLE 22 MACROLIDES MARKET, BY COUNTRY, 2019–2026 (USD MILLION)
7.6 AMINOGLYCOSIDES
7.6.1 AMINOGLYCOSIDES ARE COMMONLY USED TO CONTROL LOCAL AND SYSTEMIC INFECTIONS CAUSED BY SUSCEPTIBLE AEROBIC BACTERIA (GENERALLY GRAM-NEGATIVE)
TABLE 23 AMINOGLYCOSIDES OFFERED BY KEY MARKET PLAYERS
FIGURE 33 SALES OF AMINOGLYCOSIDES FOR FOOD-PRODUCING ANIMALS IN EUROPEAN COUNTRIES, 2017 VS. 2018 (MG/PCU)
TABLE 24 AMINOGLYCOSIDES MARKET, BY COUNTRY, 2019–2026 (USD MILLION)
7.7 LINCOSAMIDES
7.7.1 LINCOSAMIDES EXHIBIT SERIOUS SIDE EFFECTS—A KEY FACTOR LIMITING MARKET GROWTH
TABLE 25 LINCOSAMIDES OFFERED BY KEY MARKET PLAYERS
FIGURE 34 SALES OF LINCOSAMIDES FOR FOOD-PRODUCING ANIMALS IN EUROPEAN COUNTRIES, 2017 VS. 2018 (MG/PCU)
TABLE 26 LINCOSAMIDES MARKET, BY COUNTRY, 2019–2026 (USD MILLION)
7.8 FLUOROQUINOLONES
7.8.1 AVAILABILITY OF VARIATIONS IN THE ROUTE OF ADMINISTRATION RESULTS IN THE HIGHER ADOPTION OF FLUOROQUINOLONES AMONG END USERS
TABLE 27 FLUOROQUINOLONES OFFERED BY KEY MARKET PLAYERS
FIGURE 35 SALES OF FLUOROQUINOLONES FOR FOOD-PRODUCING ANIMALS IN EUROPEAN COUNTRIES, 2017 VS. 2018 (MG/PCU)
TABLE 28 FLUOROQUINOLONES MARKET, BY COUNTRY, 2019–2026 (USD MILLION)
7.9 CEPHALOSPORINS
7.9.1 CEPHALOSPORINS ARE ACTIVE AGAINST A WIDE RANGE OF BACTERIA—A KEY FACTOR DRIVING MARKET GROWTH
TABLE 29 PROPERTIES OF SEVERAL GENERATIONS OF CEPHALOSPORINS
TABLE 30 CEPHALOSPORINS OFFERED BY KEY MARKET PLAYERS
FIGURE 36 SALES OF FIRST- AND SECOND-GENERATION CEPHALOSPORINS FOR FOOD-PRODUCING ANIMALS IN EUROPEAN COUNTRIES, 2017 VS. 2018 (MG/PCU)
FIGURE 37 SALES OF THIRD- AND FOURTH-GENERATION CEPHALOSPORINS FOR FOOD-PRODUCING ANIMALS IN EUROPEAN COUNTRIES, 2017 VS. 2018 (MG/PCU)
TABLE 31 CEPHALOSPORINS MARKET, BY COUNTRY, 2019–2026 (USD MILLION)
7.10 OTHER ANTIMICROBIALS AND ANTIBIOTICS
FIGURE 38 SALES OF POLYMYXINS FOR FOOD-PRODUCING ANIMALS IN EUROPEAN COUNTRIES, 2017 VS. 2018 (MG/PCU)
TABLE 32 OTHER ANTIMICROBIALS AND ANTIBIOTICS MARKET, BY COUNTRY, 2019–2026 (USD MILLION)
8 ANIMAL ANTIMICROBIALS AND ANTIBIOTICS MARKET, BY MODE OF DELIVERY
8.1 INTRODUCTION
TABLE 33 ANIMAL ANTIMICROBIALS AND ANTIBIOTICS MARKET, BY MODE OF DELIVERY, 2019–2026 (USD MILLION)
8.2 PREMIXES
8.2.1 ADVANTAGES OF PREMIXES, SUCH AS SIMPLIFIED MODE OF ADMINISTRATION AND LOWER INSTABILITY AND HYGROSCOPICITY, TO DRIVE MARKET GROWTH
TABLE 34 ANIMAL ANTIMICROBIALS AND ANTIBIOTICS MARKET FOR PREMIXES, BY COUNTRY, 2019–2026 (USD MILLION)
8.3 ORAL SOLUTIONS
8.3.1 ORAL SOLUTIONS PRODUCE SYSTEMIC EFFECTS BUT SHOW A RELATIVELY SLOW ONSET OF ACTION
TABLE 35 ANIMAL ANTIMICROBIALS AND ANTIBIOTICS MARKET FOR ORAL SOLUTIONS, BY COUNTRY, 2019–2026 (USD MILLION)
8.4 ORAL POWDERS
8.4.1 PROPERTIES SUCH AS BETTER CHEMICAL STABILITY THAN ORAL SOLUTIONS AND FASTER DISSOLUTION THAN TABLETS AND CAPSULES TO DRIVE THE ADOPTION OF ORAL POWDERS
TABLE 36 ANIMAL ANTIMICROBIALS AND ANTIBIOTICS MARKET FOR ORAL POWDERS, BY COUNTRY, 2019–2026 (USD MILLION)
8.5 INJECTIONS
8.5.1 INJECTABLE DRUGS PROVIDE SYSTEMIC EFFECTS AND POSSESS GREATER BIOAVAILABILITY, OFFERING A FASTER ONSET OF ACTION
TABLE 37 ANIMAL ANTIMICROBIALS AND ANTIBIOTICS MARKET FOR INJECTIONS, BY COUNTRY, 2019–2026 (USD MILLION)
8.6 OTHER MODES OF DELIVERY
TABLE 38 ANIMAL ANTIMICROBIALS AND ANTIBIOTICS MARKET FOR OTHER MODES OF DELIVERY, BY COUNTRY, 2019–2026 (USD MILLION)
9 ANIMAL ANTIMICROBIALS AND ANTIBIOTICS MARKET, BY TYPE OF ANIMAL
9.1 INTRODUCTION
TABLE 39 ANIMAL ANTIMICROBIALS AND ANTIBIOTICS MARKET, BY TYPE OF ANIMAL, 2019–2026 (USD MILLION)
9.2 FOOD-PRODUCING ANIMALS
TABLE 40 GLOBAL POPULATION OF FOOD-PRODUCING ANIMALS, 1970–2030 (MILLION)
TABLE 41 PER CAPITA CONSUMPTION OF MEAT IN MAJOR APAC COUNTRIES, 2019 (IN KG)
TABLE 42 ANTIMICROBIALS AND ANTIBIOTICS MARKET FOR FOOD-PRODUCING ANIMALS, BY TYPE, 2019–2026 (USD MILLION)
TABLE 43 ANTIMICROBIALS AND ANTIBIOTICS MARKET FOR FOOD-PRODUCING ANIMALS, BY COUNTRY, 2019–2026 (USD MILLION)
9.2.1 CATTLE
9.2.1.1 Increasing beef consumption and milk production to drive growth in this market segment
TABLE 44 ANTIMICROBIALS AND ANTIBIOTICS MARKET FOR CATTLE, BY COUNTRY, 2019–2026 (USD MILLION)
9.2.2 PIGS
9.2.2.1 Growing incidence of zoonotic diseases will require better health maintenance of pigs—a key factor driving market growth
TABLE 45 ANTIMICROBIALS AND ANTIBIOTICS MARKET FOR PIGS, BY COUNTRY, 2019–2026 (USD MILLION)
9.2.3 POULTRY
9.2.3.1 Growing egg consumption in emerging countries to drive market growth
FIGURE 39 LEADING EGG PRODUCING COUNTRIES, 2018 (NUMBER OF EGGS, IN BILLION)
TABLE 46 ANTIMICROBIALS AND ANTIBIOTICS MARKET FOR POULTRY, BY COUNTRY, 2019–2026 (USD MILLION)
9.2.4 SHEEP AND GOATS
9.2.4.1 Increasing population of sheep and goats to drive growth in this segment
TABLE 47 ANTIMICROBIALS AND ANTIBIOTICS MARKET FOR SHEEP AND GOATS, BY COUNTRY, 2019–2026 (USD MILLION)
9.2.5 OTHER FOOD-PRODUCING ANIMALS
FIGURE 40 PER CAPITA FISH CONSUMPTION, 2019 VS. 2029
TABLE 48 ANTIMICROBIALS AND ANTIBIOTICS MARKET FOR OTHER FOOD-PRODUCING ANIMALS, BY COUNTRY, 2019–2026 (USD MILLION)
9.3 COMPANION ANIMALS
TABLE 49 ANTIMICROBIALS AND ANTIBIOTICS MARKET FOR COMPANION ANIMALS, BY TYPE, 2019–2026 (USD MILLION)
TABLE 50 ANTIMICROBIALS AND ANTIBIOTICS MARKET FOR COMPANION ANIMALS, BY COUNTRY, 2019–2026 (USD MILLION)
9.3.1 DOGS
9.3.1.1 Growing adoption of dogs to drive growth in this market segment
FIGURE 41 GROWING POPULATION OF PET DOGS IN INDIA (MILLION)
FIGURE 42 POPULATION OF PET DOGS GLOBALLY (MILLION)
TABLE 51 ANTIMICROBIALS AND ANTIBIOTICS MARKET FOR DOGS, BY COUNTRY, 2019–2026 (USD MILLION)
9.3.2 CATS
9.3.2.1 Growing research on feline health and wellbeing to support the market growth
TABLE 52 ANTIMICROBIALS AND ANTIBIOTICS MARKET FOR CATS, BY COUNTRY, 2019–2026 (USD MILLION)
9.3.3 HORSES
9.3.3.1 Declining horse population necessitates the adoption of health products—a key factor driving market growth
TABLE 53 ANTIMICROBIALS AND ANTIBIOTICS MARKET FOR HORSES, BY COUNTRY, 2019–2026 (USD MILLION)
9.3.4 OTHER COMPANION ANIMALS
TABLE 54 ANTIMICROBIALS AND ANTIBIOTICS MARKET FOR OTHER COMPANION ANIMALS, BY COUNTRY, 2019–2026 (USD MILLION)
10 ANIMAL ANTIMICROBIALS AND ANTIBIOTICS MARKET, BY REGION
10.1 INTRODUCTION
TABLE 55 COMPANION ANIMAL AND FOOD-PRODUCING ANIMAL POPULATION, BY COUNTRY, 2020 (IN THOUSAND)
TABLE 56 ANIMAL ANTIMICROBIALS AND ANTIBIOTICS MARKET, BY REGION, 2019–2026 (USD MILLION)
10.2 NORTH AMERICA
FIGURE 43 EXPECTED GROWTH IN THE NUMBER OF VETERINARIANS IN NORTH AMERICA
FIGURE 44 NORTH AMERICA: ANIMAL ANTIMICROBIALS AND ANTIBIOTICS MARKET SNAPSHOT
TABLE 57 NORTH AMERICA: ANIMAL ANTIMICROBIALS AND ANTIBIOTICS MARKET, BY COUNTRY, 2019–2026 (USD MILLION)
TABLE 58 NORTH AMERICA: ANIMAL ANTIMICROBIALS AND ANTIBIOTICS MARKET, BY PRODUCT, 2019–2026 (USD MILLION)
TABLE 59 NORTH AMERICA: ANIMAL ANTIMICROBIALS AND ANTIBIOTICS MARKET, BY MODE OF DELIVERY, 2019–2026 (USD MILLION)
TABLE 60 NORTH AMERICA: ANIMAL ANTIMICROBIALS AND ANTIBIOTICS MARKET, BY TYPE OF ANIMAL, 2019–2026 (USD MILLION)
TABLE 61 NORTH AMERICA: ANIMAL ANTIMICROBIALS AND ANTIBIOTICS MARKET FOR FOOD-PRODUCING ANIMALS, BY TYPE, 2019–2026 (USD MILLION)
TABLE 62 NORTH AMERICA: ANIMAL ANTIMICROBIALS AND ANTIBIOTICS MARKET FOR COMPANION ANIMALS, BY TYPE, 2019–2026 (USD MILLION)
10.2.1 US
10.2.1.1 Rising pet expenditure and increasing meat consumption are driving the market in the US
FIGURE 45 US: GROWTH IN BEEF CONSUMPTION, 2014–2019 (BILLION POUNDS)
FIGURE 46 US: INCREASE IN PET EXPENDITURE, 2010–2019 (USD BILLION)
FIGURE 47 DOMESTIC SALES AND DISTRIBUTION OF MEDICALLY IMPORTANT ANTIMICROBIAL DRUGS FOR PRODUCTION AND THERAPEUTIC INDICATIONS IN THE US (THOUSAND KG)
TABLE 63 US: PRIVATE CLINICAL PRACTICES, BY ANIMAL TYPE, 2016 VS. 2018
TABLE 64 US: ANIMAL ANTIMICROBIALS AND ANTIBIOTICS MARKET, BY PRODUCT, 2019–2026 (USD MILLION)
TABLE 65 US: ANIMAL ANTIMICROBIALS AND ANTIBIOTICS MARKET, BY MODE OF DELIVERY, 2019–2026 (USD MILLION)
TABLE 66 US: ANIMAL ANTIMICROBIALS AND ANTIBIOTICS MARKET, BY TYPE OF ANIMAL, 2019–2026 (USD MILLION)
TABLE 67 US: ANIMAL ANTIMICROBIALS AND ANTIBIOTICS MARKET FOR FOOD-PRODUCING ANIMALS, BY TYPE, 2019–2026 (USD MILLION)
TABLE 68 US: ANIMAL ANTIMICROBIALS AND ANTIBIOTICS MARKET FOR COMPANION ANIMALS, BY TYPE, 2019–2026 (USD MILLION)
10.2.2 CANADA
10.2.2.1 Growing pet adoption rate to drive the market in Canada
TABLE 69 CANADA: ANIMAL ANTIMICROBIALS AND ANTIBIOTICS MARKET, BY PRODUCT, 2019–2026 (USD MILLION)
TABLE 70 CANADA: ANIMAL ANTIMICROBIALS AND ANTIBIOTICS MARKET, BY MODE OF DELIVERY, 2019–2026 (USD MILLION)
TABLE 71 CANADA: ANIMAL ANTIMICROBIALS AND ANTIBIOTICS MARKET, BY TYPE OF ANIMAL, 2019–2026 (USD MILLION)
TABLE 72 CANADA: ANIMAL ANTIMICROBIALS AND ANTIBIOTICS MARKET FOR FOOD-PRODUCING ANIMALS, BY TYPE, 2019–2026 (USD MILLION)
TABLE 73 CANADA: ANIMAL ANTIMICROBIALS AND ANTIBIOTICS MARKET FOR COMPANION ANIMALS, BY TYPE, 2019–2026 (USD MILLION)
10.3 EUROPE
TABLE 74 EUROPE: LIVESTOCK POPULATION, BY ANIMAL, 2011–2018 (MILLION HEAD)
TABLE 75 EUROPE: ANIMAL ANTIMICROBIALS AND ANTIBIOTICS MARKET, BY COUNTRY, 2019–2026 (USD MILLION)
TABLE 76 EUROPE: ANIMAL ANTIMICROBIALS AND ANTIBIOTICS MARKET, BY PRODUCT, 2019–2026 (USD MILLION)
TABLE 77 EUROPE: ANIMAL ANTIMICROBIALS AND ANTIBIOTICS MARKET, BY MODE OF DELIVERY, 2019–2026 (USD MILLION)
TABLE 78 EUROPE: ANIMAL ANTIMICROBIALS AND ANTIBIOTICS MARKET, BY TYPE OF ANIMAL, 2019–2026 (USD MILLION)
TABLE 79 EUROPE: ANIMAL ANTIMICROBIALS AND ANTIBIOTICS MARKET FOR FOOD-PRODUCING ANIMALS, BY TYPE, 2019–2026 (USD MILLION)
TABLE 80 EUROPE: ANIMAL ANTIMICROBIALS AND ANTIBIOTICS MARKET FOR COMPANION ANIMALS, BY TYPE, 2019–2026 (USD MILLION)
10.3.1 SPAIN
10.3.1.1 Large volume of sales of important antibiotics in this country to drive market growth
TABLE 81 SPAIN: LARGE ANIMAL POPULATION, 2001–2019 (MILLION)
TABLE 82 SPAIN: ANIMAL ANTIMICROBIALS AND ANTIBIOTICS MARKET, BY PRODUCT, 2019–2026 (USD MILLION)
TABLE 83 SPAIN: ANIMAL ANTIMICROBIALS AND ANTIBIOTICS MARKET, BY MODE OF DELIVERY, 2019–2026 (USD MILLION)
TABLE 84 SPAIN: ANIMAL ANTIMICROBIALS AND ANTIBIOTICS MARKET, BY TYPE OF ANIMAL, 2019–2026 (USD MILLION)
TABLE 85 SPAIN: ANIMAL ANTIMICROBIALS AND ANTIBIOTICS MARKET FOR FOOD-PRODUCING ANIMALS, BY TYPE, 2019–2026 (USD MILLION)
TABLE 86 SPAIN: ANIMAL ANTIMICROBIALS AND ANTIBIOTICS MARKET FOR COMPANION ANIMALS, BY TYPE, 2019–2026 (USD MILLION)
10.3.2 ITALY
10.3.2.1 Need to curb zoonotic diseases in livestock will contribute to the demand for animal antimicrobials and antibiotics market in Italy
TABLE 87 ITALY: ANIMAL ANTIMICROBIALS AND ANTIBIOTICS MARKET, BY PRODUCT, 2019–2026 (USD MILLION)
TABLE 88 ITALY: ANIMAL ANTIMICROBIALS AND ANTIBIOTICS MARKET, BY MODE OF DELIVERY, 2019–2026 (USD MILLION)
TABLE 89 ITALY: ANIMAL ANTIMICROBIALS AND ANTIBIOTICS MARKET, BY TYPE OF ANIMAL, 2019–2026 (USD MILLION)
TABLE 90 ITALY: ANIMAL ANTIMICROBIALS AND ANTIBIOTICS MARKET FOR FOOD-PRODUCING ANIMALS, BY TYPE, 2019–2026 (USD MILLION)
TABLE 91 ITALY: ANIMAL ANTIMICROBIALS AND ANTIBIOTICS MARKET FOR COMPANION ANIMALS, BY TYPE, 2019–2026 (USD MILLION)
10.3.3 GERMANY
10.3.3.1 Increasing number of pets, increasing veterinary visits, and growing healthcare expenditure to boost the growth of the animal antimicrobials and antibiotics market in Germany
TABLE 92 GERMANY: COMPANION ANIMAL POPULATION, 2012–2018 (MILLION)
FIGURE 48 SALES SURVEILLANCE OF ANTIMICROBIALS FOR VETERINARY USE IN GERMANY (2011 TO 2018)
TABLE 93 GERMANY: ANIMAL ANTIMICROBIALS AND ANTIBIOTICS MARKET, BY PRODUCT, 2019–2026 (USD MILLION)
TABLE 94 GERMANY: ANIMAL ANTIMICROBIALS AND ANTIBIOTICS MARKET, BY MODE OF DELIVERY, 2019–2026 (USD MILLION)
TABLE 95 GERMANY: ANIMAL ANTIMICROBIALS AND ANTIBIOTICS MARKET, BY TYPE OF ANIMAL, 2019–2026 (USD MILLION)
TABLE 96 GERMANY: ANIMAL ANTIMICROBIALS AND ANTIBIOTICS MARKET FOR FOOD-PRODUCING ANIMALS, BY TYPE, 2019–2026 (USD MILLION)
TABLE 97 GERMANY: ANIMAL ANTIMICROBIALS AND ANTIBIOTICS MARKET FOR COMPANION ANIMALS, BY TYPE, 2019–2026 (USD MILLION)
10.3.4 FRANCE
10.3.4.1 Presence of major players has ensured the strong share of France in the overall market
TABLE 98 FRANCE: ANIMAL ANTIMICROBIALS AND ANTIBIOTICS MARKET, BY PRODUCT, 2019–2026 (USD MILLION)
TABLE 99 FRANCE: ANIMAL ANTIMICROBIALS AND ANTIBIOTICS MARKET, BY MODE OF DELIVERY, 2019–2026 (USD MILLION)
TABLE 100 FRANCE: ANIMAL ANTIMICROBIALS AND ANTIBIOTICS MARKET, BY TYPE OF ANIMAL, 2019–2026 (USD MILLION)
TABLE 101 FRANCE: ANIMAL ANTIMICROBIALS AND ANTIBIOTICS MARKET FOR FOOD-PRODUCING ANIMALS, BY TYPE, 2019–2026 (USD MILLION)
TABLE 102 FRANCE: ANIMAL ANTIMICROBIALS AND ANTIBIOTICS MARKET FOR COMPANION ANIMALS, BY TYPE, 2019–2026 (USD MILLION)
10.3.5 UK
10.3.5.1 Increasing pet ownership is expected to drive market growth
FIGURE 49 SALES OF ANTIBIOTICS FOR FOOD-PRODUCING ANIMALS IN THE UK FROM 2015 TO 2019 (MG/KG)
TABLE 103 UK: ANIMAL ANTIMICROBIALS AND ANTIBIOTICS MARKET, BY PRODUCT, 2019–2026 (USD MILLION)
TABLE 104 UK: ANIMAL ANTIMICROBIALS AND ANTIBIOTICS MARKET, BY MODE OF DELIVERY, 2019–2026 (USD MILLION)
TABLE 105 UK: ANIMAL ANTIMICROBIALS AND ANTIBIOTICS MARKET, BY TYPE OF ANIMAL, 2019–2026 (USD MILLION)
TABLE 106 UK: ANIMAL ANTIMICROBIALS AND ANTIBIOTICS MARKET FOR FOOD-PRODUCING ANIMALS, BY TYPE, 2019–2026 (USD MILLION)
TABLE 107 UK: ANIMAL ANTIMICROBIALS AND ANTIBIOTICS MARKET FOR COMPANION ANIMALS, BY TYPE, 2019–2026 (USD MILLION)
10.3.6 REST OF EUROPE
TABLE 108 ROE: ANIMAL ANTIMICROBIALS AND ANTIBIOTICS MARKET, BY PRODUCT, 2019–2026 (USD MILLION)
TABLE 109 ROE: ANIMAL ANTIMICROBIALS AND ANTIBIOTICS MARKET, BY MODE OF DELIVERY, 2019–2026 (USD MILLION)
TABLE 110 ROE: ANIMAL ANTIMICROBIALS AND ANTIBIOTICS MARKET, BY TYPE OF ANIMAL, 2019–2026 (USD MILLION)
TABLE 111 ROE: ANIMAL ANTIMICROBIALS AND ANTIBIOTICS MARKET FOR FOOD-PRODUCING ANIMALS, BY TYPE, 2019–2026 (USD MILLION)
TABLE 112 ROE: ANIMAL ANTIMICROBIALS AND ANTIBIOTICS MARKET FOR COMPANION ANIMALS, BY TYPE, 2019–2026 (USD MILLION)
10.4 ASIA PACIFIC (APAC)
TABLE 113 ASIA PACIFIC: FOOD-PRODUCING ANIMAL POPULATION, 2010–2017 (MILLION)
FIGURE 50 ASIA PACIFIC: ANIMAL ANTIMICROBIALS AND ANTIBIOTICS MARKET SNAPSHOT
TABLE 114 ASIA PACIFIC: ANIMAL ANTIMICROBIALS AND ANTIBIOTICS MARKET, BY COUNTRY, 2019–2026 (USD MILLION)
TABLE 115 ASIA PACIFIC: ANIMAL ANTIMICROBIALS AND ANTIBIOTICS MARKET, BY PRODUCT, 2019–2026 (USD MILLION)
TABLE 116 ASIA PACIFIC: ANIMAL ANTIMICROBIALS AND ANTIBIOTICS MARKET, BY MODE OF DELIVERY, 2019–2026 (USD MILLION)
TABLE 117 ASIA PACIFIC: ANIMAL ANTIMICROBIALS AND ANTIBIOTICS MARKET, BY TYPE OF ANIMAL, 2019–2026 (USD MILLION)
TABLE 118 ASIA PACIFIC: ANIMAL ANTIMICROBIALS AND ANTIBIOTICS MARKET FOR FOOD-PRODUCING ANIMALS, BY TYPE, 2019–2026 (USD MILLION)
TABLE 119 ASIA PACIFIC: ANIMAL ANTIMICROBIALS AND ANTIBIOTICS MARKET FOR COMPANION ANIMALS, BY TYPE, 2019–2026 (USD MILLION)
10.4.1 CHINA
10.4.1.1 China dominates the APAC animal antimicrobials and antibiotics market
TABLE 120 CHINA: FOOD-PRODUCING ANIMAL POPULATION, 2012–2019 (MILLION)
TABLE 121 CHINA: ANIMAL ANTIMICROBIALS AND ANTIBIOTICS MARKET, BY PRODUCT, 2019–2026 (USD MILLION)
TABLE 122 CHINA: ANIMAL ANTIMICROBIALS AND ANTIBIOTICS MARKET, BY MODE OF DELIVERY, 2019–2026 (USD MILLION)
TABLE 123 CHINA: ANIMAL ANTIMICROBIALS AND ANTIBIOTICS MARKET, BY TYPE OF ANIMAL, 2019–2026 (USD MILLION)
TABLE 124 CHINA: ANIMAL ANTIMICROBIALS AND ANTIBIOTICS MARKET FOR FOOD-PRODUCING ANIMALS, BY TYPE, 2019–2026 (USD MILLION)
TABLE 125 CHINA: ANIMAL ANTIMICROBIALS AND ANTIBIOTICS MARKET FOR COMPANION ANIMALS, BY TYPE, 2019–2026 (USD MILLION)
10.4.2 JAPAN
10.4.2.1 Rising demand for imported breeds is driving pet adoption in the country
TABLE 126 PRODUCTION AND CONSUMPTION OF ANIMAL-DERIVED FOOD PRODUCTS
IN JAPAN (2000 VS. 2030) (THOUSAND METRIC TONS)
FIGURE 51 VOLUMES OF VETERINARY ANTIMICROBIALS SOLD BY PHARMACEUTICAL COMPANIES IN JAPAN, 2001–2017 (IN TONS OF ACTIVE INGREDIENT)
FIGURE 52 AMOUNT OF ANTIMICROBIAL FEED ADDITIVES MANUFACTURED IN JAPAN, 2003–2017 (IN TONS OF ACTIVE INGREDIENT)
TABLE 127 JAPAN: ANIMAL ANTIMICROBIALS AND ANTIBIOTICS MARKET, BY PRODUCT, 2019–2026 (USD MILLION)
TABLE 128 JAPAN: ANIMAL ANTIMICROBIALS AND ANTIBIOTICS MARKET, BY MODE OF DELIVERY, 2019–2026 (USD MILLION)
TABLE 129 JAPAN: ANIMAL ANTIMICROBIALS AND ANTIBIOTICS MARKET, BY TYPE OF ANIMAL, 2019–2026 (USD MILLION)
TABLE 130 JAPAN: ANIMAL ANTIMICROBIALS AND ANTIBIOTICS MARKET FOR FOOD-PRODUCING ANIMALS, BY TYPE, 2019–2026 (USD MILLION)
TABLE 131 JAPAN: ANIMAL ANTIMICROBIALS AND ANTIBIOTICS MARKET FOR COMPANION ANIMALS, BY TYPE, 2019–2026 (USD MILLION)
10.4.3 INDIA
10.4.3.1 Rising food-producing animal population and growing awareness about animal health will contribute to market growth during the forecast period
TABLE 132 PRODUCTION AND CONSUMPTION OF ANIMAL-DERIVED FOOD PRODUCTS IN INDIA (2000 VS. 2030) (THOUSAND METRIC TONS)
TABLE 133 INDIA: ANIMAL ANTIMICROBIALS AND ANTIBIOTICS MARKET, BY PRODUCT, 2019–2026 (USD MILLION)
TABLE 134 INDIA: ANIMAL ANTIMICROBIALS AND ANTIBIOTICS MARKET, BY MODE OF DELIVERY, 2019–2026 (USD MILLION)
TABLE 135 INDIA: ANIMAL ANTIMICROBIALS AND ANTIBIOTICS MARKET, BY TYPE OF ANIMAL, 2019–2026 (USD MILLION)
TABLE 136 INDIA: ANIMAL ANTIMICROBIALS AND ANTIBIOTICS MARKET FOR FOOD-PRODUCING ANIMALS, BY TYPE, 2019–2026 (USD MILLION)
TABLE 137 INDIA: ANIMAL ANTIMICROBIALS AND ANTIBIOTICS MARKET FOR COMPANION ANIMALS, BY TYPE, 2019–2026 (USD MILLION)
10.4.4 REST OF ASIA PACIFIC (REST OF APAC)
TABLE 138 REGULATORY SCENARIO FOR ANTIBIOTICS IN THE ROAPAC, BY COUNTRY
TABLE 139 REST OF APAC: ANIMAL ANTIMICROBIALS AND ANTIBIOTICS MARKET, BY PRODUCT, 2019–2026 (USD MILLION)
TABLE 140 REST OF APAC: ANIMAL ANTIMICROBIALS AND ANTIBIOTICS MARKET, BY MODE OF DELIVERY, 2019–2026 (USD MILLION)
TABLE 141 REST OF APAC: ANIMAL ANTIMICROBIALS AND ANTIBIOTICS MARKET, BY TYPE OF ANIMAL, 2019–2026 (USD MILLION)
TABLE 142 REST OF APAC: ANIMAL ANTIMICROBIALS AND ANTIBIOTICS MARKET FOR FOOD-PRODUCING ANIMALS, BY TYPE, 2019–2026 (USD MILLION)
TABLE 143 REST OF APAC: ANIMAL ANTIMICROBIALS AND ANTIBIOTICS MARKET FOR COMPANION ANIMALS, BY TYPE, 2019–2026 (USD MILLION)
10.5 LATIN AMERICA
TABLE 144 LATIN AMERICA: FOOD-PRODUCING ANIMALS POPULATION, BY COUNTRY (2010–2014) (MILLION)
TABLE 145 LATIN AMERICA: ANIMAL ANTIMICROBIALS AND ANTIBIOTICS MARKET, BY PRODUCT, 2019–2026 (USD MILLION)
TABLE 146 LATIN AMERICA: ANIMAL ANTIMICROBIALS AND ANTIBIOTICS MARKET, BY MODE OF DELIVERY, 2019–2026 (USD MILLION)
TABLE 147 LATIN AMERICA: ANIMAL ANTIMICROBIALS AND ANTIBIOTICS MARKET, BY TYPE OF ANIMAL, 2019–2026 (USD MILLION)
TABLE 148 LATIN AMERICA: ANIMAL ANTIMICROBIALS AND ANTIBIOTICS MARKET FOR FOOD-PRODUCING ANIMALS, BY TYPE, 2019–2026 (USD MILLION)
TABLE 149 LATIN AMERICA: ANIMAL ANTIMICROBIALS AND ANTIBIOTICS MARKET FOR COMPANION ANIMALS, BY TYPE, 2019–2026 (USD MILLION)
10.6 MIDDLE EAST & AFRICA
TABLE 150 AFRICA: NUMBER OF VETERINARIANS, 2010 VS. 2014 VS. 2016
TABLE 151 MIDDLE EAST & AFRICA: ANIMAL ANTIMICROBIALS AND ANTIBIOTICS MARKET, BY PRODUCT, 2019–2026 (USD MILLION)
TABLE 152 MIDDLE EAST & AFRICA: ANIMAL ANTIMICROBIALS AND ANTIBIOTICS MARKET, BY MODE OF DELIVERY, 2019–2026 (USD MILLION)
TABLE 153 MIDDLE EAST & AFRICA: ANIMAL ANTIMICROBIALS AND ANTIBIOTICS MARKET, BY TYPE OF ANIMAL, 2019–2026 (USD MILLION)
TABLE 154 MIDDLE EAST & AFRICA: ANIMAL ANTIMICROBIALS AND ANTIBIOTICS MARKET FOR FOOD-PRODUCING ANIMALS, BY TYPE, 2019–2026 (USD MILLION)
TABLE 155 MIDDLE EAST & AFRICA: ANIMAL ANTIMICROBIALS AND ANTIBIOTICS MARKET FOR COMPANION ANIMALS, BY TYPE, 2019–2026 (USD MILLION)
11 COMPETITIVE LANDSCAPE
11.1 INTRODUCTION
FIGURE 53 KEY DEVELOPMENTS OF MAJOR PLAYERS BETWEEN 2017 AND JAN 2021
11.2 MARKET EVALUATION FRAMEWORK
FIGURE 54 MARKET EVALUATION FRAMEWORK: ACQUISITIONS—THE MOST WIDELY ADOPTED STRATEGY
11.3 PRODUCT PORTFOLIO MATRIX
TABLE 156 PLAYERS IN THE ANIMAL ANTIMICROBIALS AND ANTIBIOTICS MARKET: PRODUCT PORTFOLIO ANALYSIS
11.4 ANIMAL ANTIMICROBIALS AND ANTIBIOTICS MARKET: GEOGRAPHICAL ASSESSMENT
FIGURE 55 GEOGRAPHIC ASSESSMENT OF KEY PLAYERS IN THE ANIMAL ANTIMICROBIALS AND ANTIBIOTICS MARKET (2019)
11.5 ANIMAL ANTIMICROBIALS AND ANTIBIOTICS MARKET: R&D EXPENDITURE
FIGURE 56 R&D EXPENDITURE OF KEY PLAYERS IN THE ANIMAL ANTIMICROBIALS AND ANTIBIOTICS MARKET (2019)
11.6 REVENUE ANALYSIS: TOP 5 PLAYERS
FIGURE 57 ANIMAL ANTIMICROBIALS AND ANTIBIOTICS MARKET: REVENUE ANALYSIS (2019)
11.7 VENDOR DIVE
11.7.1 STARS
11.7.2 EMERGING LEADERS
11.7.3 PERVASIVE PLAYERS
11.7.4 EMERGING COMPANIES
FIGURE 58 COMPETITIVE LEADERSHIP MAPPING: ANIMAL ANTIMICROBIALS AND ANTIBIOTICS MARKET, 2020
11.8 MARKET SHARE ANALYSIS
TABLE 157 ANIMAL ANTIMICROBIALS AND ANTIBIOTICS MARKET: DEGREE OF COMPETITION
FIGURE 59 ANIMAL ANTIMICROBIALS AND ANTIBIOTICS MARKET SHARE ANALYSIS, BY KEY PLAYER, 2020
11.9 COMPETITIVE SITUATION AND TRENDS
11.9.1 PRODUCT LAUNCHES & APPROVALS
TABLE 158 PRODUCT LAUNCHES & APPROVALS
11.9.2 PARTNERSHIPS, AGREEMENTS, AND COLLABORATIONS
TABLE 159 PARTNERSHIPS, AGREEMENTS, AND COLLABORATIONS
11.9.3 MERGERS, ACQUISITIONS, AND DIVESTITURES
TABLE 160 MERGERS, ACQUISITIONS, AND DIVESTITURES
11.9.4 EXPANSIONS
TABLE 161 EXPANSIONS
11.10 SME MATRIX
11.10.1 COMPETITIVE LEADERSHIP MAPPING (SMES)
11.10.1.1 Progressive companies
11.10.1.2 Starting blocks
11.10.1.3 Responsive companies
11.10.1.4 Dynamic companies
FIGURE 60 ANIMAL ANTIMICROBIALS AND ANTIBIOTICS MARKET: COMPETITIVE LEADERSHIP MAPPING FOR SME, 2020
12 COMPETITIVE EVALUATION MATRIX AND COMPANY PROFILES
12.1 KEY PLAYERS
(Business overview, Products offered, Recent developments, MNM view)*
12.1.1 ZOETIS, INC.
TABLE 162 ZOETIS, INC.: BUSINESS OVERVIEW
FIGURE 61 ZOETIS: COMPANY SNAPSHOT (2019)
12.1.2 MERCK & CO., INC.
TABLE 163 MERCK AND CO., INC: BUSINESS OVERVIEW
FIGURE 62 MERCK & CO., INC.: COMPANY SNAPSHOT (2019)
12.1.3 BOEHRINGER INGELHEIM GMBH
TABLE 164 BOEHRINGER INGELHEIM GMBH: BUSINESS OVERVIEW
FIGURE 63 BOEHRINGER INGELHEIM GMBH: COMPANY SNAPSHOT (2019)
12.1.4 ELANCO ANIMAL HEALTH
TABLE 165 ELANCO ANIMAL HEALTH: BUSINESS OVERVIEW
FIGURE 64 ELANCO ANIMAL HEALTH: COMPANY SNAPSHOT (2019)
12.1.5 CEVA SANT? ANIMALE
TABLE 166 CEVA SANT? ANIMALE: BUSINESS OVERVIEW
12.1.6 VIRBAC
TABLE 167 VIRBAC: BUSINESS OVERVIEW
FIGURE 65 VIRBAC: COMPANY SNAPSHOT (2019)
12.1.7 VETOQUINOL SA.
TABLE 168 VETOQUINOL S.A.: BUSINESS OVERVIEW
FIGURE 66 VETOQUINOL SA: COMPANY SNAPSHOT (2019)
12.1.8 DECHRA PHARMACEUTICALS PLC
TABLE 169 DECHRA PHARMACEUTICALS PLC: BUSINESS OVERVIEW
FIGURE 67 DECHRA PHARMACEUTICALS PLC: COMPANY SNAPSHOT (2019)
12.1.9 PHIBRO ANIMAL HEALTH
TABLE 170 PHIBRO ANIMAL HEALTH: BUSINESS OVERVIEW
FIGURE 68 PHIBRO ANIMAL HEALTH: COMPANY SNAPSHOT (2019)
12.1.10 KYORITSU SEIYAKU
TABLE 171 KYORITSU SEIYAKU: BUSINESS OVERVIEW
12.1.11 ZYDUS ANIMAL HEALTH
TABLE 172 ZYDUS ANIMAL HEALTH: BUSINESS OVERVIEW
FIGURE 69 ZYDUS: COMPANY SNAPSHOT (2019)
12.1.12 TIANJIN RINGPU
TABLE 173 TIANJIN RINGPU: BUSINESS OVERVIEW
12.1.13 HIPRA
TABLE 174 HIPRA: BUSINESS OVERVIEW
12.1.14 CHINA ANIMAL HUSBANDRY
TABLE 175 CHINA ANIMAL HUSBANDRY: BUSINESS OVERVIEW
12.1.15 INOVET
TABLE 176 INOVET: BUSINESS OVERVIEW
*Business overview, Products offered, Recent developments, MNM view might not be captured in case of unlisted companies.
12.2 OTHER EMERGING COMPANIES
12.2.1 ENDOVAC ANIMAL HEALTH
12.2.2 ECO ANIMAL HEALTH GROUP PLC
12.2.3 INDIAN IMMUNOLOGICALS LTD.
12.2.4 ASHISH LIFE SCIENCE (ALS)
12.2.5 LUTIM PHARMA
13 APPENDIX
13.1 DISCUSSION GUIDE
13.2 KNOWLEDGE STORE: MARKETSANDMARKETS’ SUBSCRIPTION PORTAL
13.3 AVAILABLE CUSTOMIZATIONS
13.4 RELATED REPORTS
13.5 AUTHOR DETAILS
1.1 OBJECTIVES OF THE STUDY
1.2 MARKET DEFINITION
1.2.1 INCLUSIONS AND EXCLUSIONS
1.2.2 MARKETS COVERED
1.2.3 YEARS CONSIDERED FOR THE STUDY
1.3 CURRENCY
TABLE 1 EXCHANGE RATES UTILIZED FOR CONVERSION TO USD
1.4 LIMITATIONS
1.5 STAKEHOLDERS
1.6 SUMMARY OF CHANGES
2 RESEARCH METHODOLOGY
2.1 RESEARCH DATA
FIGURE 1 RESEARCH DESIGN
2.1.1 SECONDARY DATA
2.1.1.1 Key data from secondary sources
2.1.2 PRIMARY DATA
FIGURE 2 PRIMARY SOURCES
2.1.2.1 Key data from primary sources
2.1.2.2 Key industry insights
FIGURE 3 BREAKDOWN OF PRIMARY INTERVIEWS: BY COMPANY TYPE, DESIGNATION, AND REGION
2.2 MARKET SIZE ESTIMATION
FIGURE 4 SUPPLY-SIDE MARKET SIZE ESTIMATION: REVENUE SHARE ANALYSIS
FIGURE 5 REVENUE SHARE ANALYSIS ILLUSTRATION
FIGURE 6 COUNTRY-LEVEL ANALYSIS OF THE ANIMAL ANTIMICROBIALS AND ANTIBIOTICS MARKET
FIGURE 7 CAGR PROJECTIONS: SUPPLY-SIDE ANALYSIS
FIGURE 8 TOP-DOWN APPROACH
2.3 MARKET BREAKDOWN & DATA TRIANGULATION
FIGURE 9 MARKET DATA TRIANGULATION METHODOLOGY
2.4 MARKET SHARE ANALYSIS
2.5 ASSUMPTIONS FOR THE STUDY
3 EXECUTIVE SUMMARY
FIGURE 10 ANIMAL ANTIMICROBIALS AND ANTIBIOTICS MARKET, BY PRODUCT, 2021 VS. 2026 (USD MILLION)
FIGURE 11 ANIMAL ANTIMICROBIALS AND ANTIBIOTICS MARKET, BY MODE OF DELIVERY, 2021 VS. 2026 (USD MILLION)
FIGURE 12 ANIMAL ANTIMICROBIALS AND ANTIBIOTICS MARKET, BY ANIMAL TYPE, 2021 VS. 2026 (USD MILLION)
FIGURE 13 GEOGRAPHICAL SNAPSHOT OF THE GLOBAL ANIMAL ANTIMICROBIALS AND ANTIBIOTICS MARKET
4 PREMIUM INSIGHTS
4.1 ANIMAL ANTIMICROBIALS AND ANTIBIOTICS MARKET OVERVIEW
FIGURE 14 RISING DEMAND FOR ANIMAL-DERIVED FOOD PRODUCTS AND GROWING INCIDENCE OF ZOONOTIC DISEASES TO DRIVE MARKET GROWTH
4.2 ASIA PACIFIC: ANIMAL ANTIMICROBIALS AND ANTIBIOTICS MARKET, BY MODE OF DELIVERY AND COUNTRY (2020)
FIGURE 15 CHINA ACCOUNTED FOR THE LARGEST SHARE OF THE APAC ANIMAL ANTIMICROBIALS AND ANTIBIOTICS MARKET IN 2020
4.3 ANIMAL ANTIMICROBIALS AND ANTIBIOTICS MARKET: GEOGRAPHIC GROWTH OPPORTUNITIES
FIGURE 16 CHINA TO REGISTER THE HIGHEST GROWTH RATE DURING THE FORECAST PERIOD
4.4 REGIONAL MIX: ANIMAL ANTIMICROBIALS AND ANTIBIOTICS MARKET (2021?2026)
FIGURE 17 NORTH AMERICA WILL CONTINUE TO DOMINATE THE ANIMAL ANTIMICROBIALS AND ANTIBIOTICS MARKET IN 2026
4.5 ANIMAL ANTIMICROBIALS AND ANTIBIOTICS MARKET: DEVELOPED VS. DEVELOPING MARKETS
FIGURE 18 DEVELOPING MARKETS TO REGISTER HIGHER GROWTH RATES DURING THE FORECAST PERIOD
5 MARKET OVERVIEW
5.1 INTRODUCTION
5.2 MARKET DYNAMICS
TABLE 2 DRIVERS, RESTRAINTS, OPPORTUNITIES, AND CHALLENGES: IMPACT ANALYSIS
5.2.1 DRIVERS
5.2.1.1 Rising demand for animal-derived food products
TABLE 3 PAST AND PROJECTED TRENDS IN THE CONSUMPTION OF MEAT AND MILK IN DEVELOPED AND DEVELOPING REGIONS
FIGURE 19 ASIA: COUNTRY-LEVEL CONSUMPTION OF ANIMAL-DERIVED FOOD PRODUCTS, 2020 VS. 2030 (THOUSAND METRIC TONS)
FIGURE 20 ASIA: COUNTRY-LEVEL PRODUCTION OF ANIMAL-DERIVED FOOD PRODUCTS, 2020 VS. 2030 (THOUSAND METRIC TONS)
FIGURE 21 ASIA WAS THE HIGHEST CONSUMER OF MEAT AND MILK IN THE WORLD IN 2018
5.2.1.2 Increasing incidence of zoonotic diseases
TABLE 4 ANIMAL DISEASE OUTBREAKS IN ASIA PACIFIC COUNTRIES (2009–2019)
5.2.1.3 Increasing investments from private players
5.2.1.4 Rising demand for pet insurance and growing animal health expenditure
FIGURE 22 NORTH AMERICA: PET HEALTH INSURANCE MARKET, 2014 VS. 2019 (USD MILLION)
5.2.2 RESTRAINTS
5.2.2.1 Limited number of new antibiotics
5.2.2.2 Growing resistance to antimicrobials and antibiotics
5.2.2.3 Routine prophylactic use of antibiotics being replaced by good husbandry, probiotics, and hygiene practices
5.2.3 OPPORTUNITIES
5.2.3.1 Untapped emerging markets
5.2.3.2 Growth in the companion animal population
TABLE 5 US: COMPANION ANIMAL POPULATION (2010–2025)
TABLE 6 UK : COMPANION ANIMAL POPULATION (2010–2025)
TABLE 7 INDIA : COMPANION ANIMAL POPULATION IN (2010–2025)
TABLE 8 SAUDI ARABIA: COMPANION ANIMAL POPULATION (2010–2025)
5.2.4 CHALLENGES
5.2.4.1 Stringent approval process for antimicrobials and antibiotics
6 INDUSTRY INSIGHTS
6.1 INTRODUCTION
6.2 COVID-19 IMPACT ANALYSIS
6.2.1 IMPACT OF COVID-19 ON THE ANIMAL ANTIMICROBIALS AND ANTIBIOTICS MARKET
6.3 INDUSTRY TRENDS
FIGURE 23 GROWING CONSOLIDATION IN THE ANIMAL HEALTH INDUSTRY IS A MAJOR TREND IN THE ANIMAL ANTIMICROBIALS & ANTIBIOTICS MARKET
6.3.1 GROWING CONSOLIDATION IN THE ANIMAL HEALTH INDUSTRY
TABLE 9 SOME MAJOR ACQUISITIONS IN THE ANIMAL HEALTH INDUSTRY
(2017–2019)
6.3.2 GROWING FOCUS ON LIMITING THE USE OF ANTIBIOTICS IN LIVESTOCK ANIMALS
6.3.3 HIGH GROWTH IN EMERGING MARKETS
6.4 REGULATORY ANALYSIS
FIGURE 24 DEVELOPMENT AND APPROVAL PROCESS FOR ANIMAL PHARMACEUTICAL PRODUCTS
6.5 VALUE CHAIN ANALYSIS
FIGURE 25 ANIMAL ANTIMICROBIALS AND ANTIBODY MARKET: VALUE CHAIN ANALYSIS
6.6 ECOSYSTEM MARKET MAP
TABLE 10 ANIMAL ANTIMICROBIALS AND ANTIBIOTICS MARKET: ECOSYSTEM MAPPING
FIGURE 26 ANIMAL ANTIMICROBIALS AND ANTIBIOTICS MARKET: ECOSYSTEM MARKET MAP
6.7 PORTER’S FIVE FORCES ANALYSIS
TABLE 11 ANIMAL ANTIMICROBIALS AND ANTIBIOTICS MARKET: PORTER’S FIVE FORCES ANALYSIS
6.7.1 THREAT FROM NEW ENTRANTS
6.7.2 THREAT FROM SUBSTITUTES
6.7.3 BARGAINING POWER OF SUPPLIERS
6.7.4 BARGAINING POWER OF BUYERS
6.7.5 INTENSITY OF COMPETITIVE RIVALRY
6.8 SUPPLY CHAIN ANALYSIS
FIGURE 27 ANIMAL ANTIMICROBIALS AND ANTIBIOTICS MARKET: SUPPLY CHAIN ANALYSIS
6.9 PATENT ANALYSIS
TABLE 12 LIST OF ANTIBIOTICS AND THEIR PATENT YEARS
6.10 PRICING ANALYSIS
7 ANIMAL ANTIMICROBIALS AND ANTIBIOTICS MARKET, BY PRODUCT
7.1 INTRODUCTION
FIGURE 28 SALES OF ANTIMICROBIAL AGENTS, BY ANTIMICROBIAL CLASS, AS A PERCENTAGE OF THE TOTAL SALES FOR FOOD-PRODUCING SPECIES (IN MG/PCU): AGGREGATED BY 31 EUROPEAN COUNTRIES, 2018
TABLE 13 ANIMAL ANTIMICROBIALS AND ANTIBIOTICS MARKET, BY PRODUCT, 2019–2026 (USD MILLION)
TABLE 14 ANIMAL ANTIMICROBIALS AND ANTIBIOTICS MARKET, BY COUNTRY, 2019–2026 (USD MILLION)
7.2 TETRACYCLINES
7.2.1 REDUCED COST OF TETRACYCLINES IS A KEY FACTOR DRIVING MARKET GROWTH ACROSS THE GLOBE
TABLE 15 TETRACYCLINES OFFERED BY KEY MARKET PLAYERS
FIGURE 29 SALES OF TETRACYCLINES FOR FOOD-PRODUCING ANIMALS IN EUROPEAN COUNTRIES, 2017 VS. 2018 (MG/PCU)
TABLE 16 TETRACYCLINES MARKET, BY COUNTRY, 2019–2026 (USD MILLION)
7.3 PENICILLINS
7.3.1 RISING INCIDENCE OF ZOONOTIC DISEASES IN LIVESTOCK ANIMALS TO DRIVE THE DEMAND FOR PENICILLINS
TABLE 17 PENICILLINS OFFERED BY KEY MARKET PLAYERS
FIGURE 30 SALES OF PENICILLINS FOR FOOD-PRODUCING ANIMALS IN EUROPEAN COUNTRIES, 2017 VS. 2018 (MG/PCU)
TABLE 18 PENICILLINS MARKET, BY COUNTRY, 2019–2026 (USD MILLION)
7.4 SULFONAMIDES
7.4.1 REDUCED COST AND MULTIPLE APPLICATIONS IN LIVESTOCK INFECTIONS TO DRIVE THE DEMAND FOR SULFONAMIDES IN RURAL REGIONS
TABLE 19 SULFONAMIDES OFFERED BY KEY MARKET PLAYERS
FIGURE 31 SALES OF SULFONAMIDES FOR FOOD-PRODUCING ANIMALS IN EUROPEAN COUNTRIES, 2017 VS. 2018 (MG/PCU)
TABLE 20 SULFONAMIDES MARKET, BY COUNTRY, 2019–2026 (USD MILLION)
7.5 MACROLIDES
7.5.1 INCREASING PRODUCTION OF CATTLE-DERIVED FOOD PRODUCTS TO BOOST THE DEMAND FOR MACROLIDES
TABLE 21 MACROLIDES OFFERED BY KEY MARKET PLAYERS
FIGURE 32 SALES OF MACROLIDES FOR FOOD-PRODUCING ANIMALS IN EUROPEAN COUNTRIES, 2017 VS. 2018 (MG/PCU)
TABLE 22 MACROLIDES MARKET, BY COUNTRY, 2019–2026 (USD MILLION)
7.6 AMINOGLYCOSIDES
7.6.1 AMINOGLYCOSIDES ARE COMMONLY USED TO CONTROL LOCAL AND SYSTEMIC INFECTIONS CAUSED BY SUSCEPTIBLE AEROBIC BACTERIA (GENERALLY GRAM-NEGATIVE)
TABLE 23 AMINOGLYCOSIDES OFFERED BY KEY MARKET PLAYERS
FIGURE 33 SALES OF AMINOGLYCOSIDES FOR FOOD-PRODUCING ANIMALS IN EUROPEAN COUNTRIES, 2017 VS. 2018 (MG/PCU)
TABLE 24 AMINOGLYCOSIDES MARKET, BY COUNTRY, 2019–2026 (USD MILLION)
7.7 LINCOSAMIDES
7.7.1 LINCOSAMIDES EXHIBIT SERIOUS SIDE EFFECTS—A KEY FACTOR LIMITING MARKET GROWTH
TABLE 25 LINCOSAMIDES OFFERED BY KEY MARKET PLAYERS
FIGURE 34 SALES OF LINCOSAMIDES FOR FOOD-PRODUCING ANIMALS IN EUROPEAN COUNTRIES, 2017 VS. 2018 (MG/PCU)
TABLE 26 LINCOSAMIDES MARKET, BY COUNTRY, 2019–2026 (USD MILLION)
7.8 FLUOROQUINOLONES
7.8.1 AVAILABILITY OF VARIATIONS IN THE ROUTE OF ADMINISTRATION RESULTS IN THE HIGHER ADOPTION OF FLUOROQUINOLONES AMONG END USERS
TABLE 27 FLUOROQUINOLONES OFFERED BY KEY MARKET PLAYERS
FIGURE 35 SALES OF FLUOROQUINOLONES FOR FOOD-PRODUCING ANIMALS IN EUROPEAN COUNTRIES, 2017 VS. 2018 (MG/PCU)
TABLE 28 FLUOROQUINOLONES MARKET, BY COUNTRY, 2019–2026 (USD MILLION)
7.9 CEPHALOSPORINS
7.9.1 CEPHALOSPORINS ARE ACTIVE AGAINST A WIDE RANGE OF BACTERIA—A KEY FACTOR DRIVING MARKET GROWTH
TABLE 29 PROPERTIES OF SEVERAL GENERATIONS OF CEPHALOSPORINS
TABLE 30 CEPHALOSPORINS OFFERED BY KEY MARKET PLAYERS
FIGURE 36 SALES OF FIRST- AND SECOND-GENERATION CEPHALOSPORINS FOR FOOD-PRODUCING ANIMALS IN EUROPEAN COUNTRIES, 2017 VS. 2018 (MG/PCU)
FIGURE 37 SALES OF THIRD- AND FOURTH-GENERATION CEPHALOSPORINS FOR FOOD-PRODUCING ANIMALS IN EUROPEAN COUNTRIES, 2017 VS. 2018 (MG/PCU)
TABLE 31 CEPHALOSPORINS MARKET, BY COUNTRY, 2019–2026 (USD MILLION)
7.10 OTHER ANTIMICROBIALS AND ANTIBIOTICS
FIGURE 38 SALES OF POLYMYXINS FOR FOOD-PRODUCING ANIMALS IN EUROPEAN COUNTRIES, 2017 VS. 2018 (MG/PCU)
TABLE 32 OTHER ANTIMICROBIALS AND ANTIBIOTICS MARKET, BY COUNTRY, 2019–2026 (USD MILLION)
8 ANIMAL ANTIMICROBIALS AND ANTIBIOTICS MARKET, BY MODE OF DELIVERY
8.1 INTRODUCTION
TABLE 33 ANIMAL ANTIMICROBIALS AND ANTIBIOTICS MARKET, BY MODE OF DELIVERY, 2019–2026 (USD MILLION)
8.2 PREMIXES
8.2.1 ADVANTAGES OF PREMIXES, SUCH AS SIMPLIFIED MODE OF ADMINISTRATION AND LOWER INSTABILITY AND HYGROSCOPICITY, TO DRIVE MARKET GROWTH
TABLE 34 ANIMAL ANTIMICROBIALS AND ANTIBIOTICS MARKET FOR PREMIXES, BY COUNTRY, 2019–2026 (USD MILLION)
8.3 ORAL SOLUTIONS
8.3.1 ORAL SOLUTIONS PRODUCE SYSTEMIC EFFECTS BUT SHOW A RELATIVELY SLOW ONSET OF ACTION
TABLE 35 ANIMAL ANTIMICROBIALS AND ANTIBIOTICS MARKET FOR ORAL SOLUTIONS, BY COUNTRY, 2019–2026 (USD MILLION)
8.4 ORAL POWDERS
8.4.1 PROPERTIES SUCH AS BETTER CHEMICAL STABILITY THAN ORAL SOLUTIONS AND FASTER DISSOLUTION THAN TABLETS AND CAPSULES TO DRIVE THE ADOPTION OF ORAL POWDERS
TABLE 36 ANIMAL ANTIMICROBIALS AND ANTIBIOTICS MARKET FOR ORAL POWDERS, BY COUNTRY, 2019–2026 (USD MILLION)
8.5 INJECTIONS
8.5.1 INJECTABLE DRUGS PROVIDE SYSTEMIC EFFECTS AND POSSESS GREATER BIOAVAILABILITY, OFFERING A FASTER ONSET OF ACTION
TABLE 37 ANIMAL ANTIMICROBIALS AND ANTIBIOTICS MARKET FOR INJECTIONS, BY COUNTRY, 2019–2026 (USD MILLION)
8.6 OTHER MODES OF DELIVERY
TABLE 38 ANIMAL ANTIMICROBIALS AND ANTIBIOTICS MARKET FOR OTHER MODES OF DELIVERY, BY COUNTRY, 2019–2026 (USD MILLION)
9 ANIMAL ANTIMICROBIALS AND ANTIBIOTICS MARKET, BY TYPE OF ANIMAL
9.1 INTRODUCTION
TABLE 39 ANIMAL ANTIMICROBIALS AND ANTIBIOTICS MARKET, BY TYPE OF ANIMAL, 2019–2026 (USD MILLION)
9.2 FOOD-PRODUCING ANIMALS
TABLE 40 GLOBAL POPULATION OF FOOD-PRODUCING ANIMALS, 1970–2030 (MILLION)
TABLE 41 PER CAPITA CONSUMPTION OF MEAT IN MAJOR APAC COUNTRIES, 2019 (IN KG)
TABLE 42 ANTIMICROBIALS AND ANTIBIOTICS MARKET FOR FOOD-PRODUCING ANIMALS, BY TYPE, 2019–2026 (USD MILLION)
TABLE 43 ANTIMICROBIALS AND ANTIBIOTICS MARKET FOR FOOD-PRODUCING ANIMALS, BY COUNTRY, 2019–2026 (USD MILLION)
9.2.1 CATTLE
9.2.1.1 Increasing beef consumption and milk production to drive growth in this market segment
TABLE 44 ANTIMICROBIALS AND ANTIBIOTICS MARKET FOR CATTLE, BY COUNTRY, 2019–2026 (USD MILLION)
9.2.2 PIGS
9.2.2.1 Growing incidence of zoonotic diseases will require better health maintenance of pigs—a key factor driving market growth
TABLE 45 ANTIMICROBIALS AND ANTIBIOTICS MARKET FOR PIGS, BY COUNTRY, 2019–2026 (USD MILLION)
9.2.3 POULTRY
9.2.3.1 Growing egg consumption in emerging countries to drive market growth
FIGURE 39 LEADING EGG PRODUCING COUNTRIES, 2018 (NUMBER OF EGGS, IN BILLION)
TABLE 46 ANTIMICROBIALS AND ANTIBIOTICS MARKET FOR POULTRY, BY COUNTRY, 2019–2026 (USD MILLION)
9.2.4 SHEEP AND GOATS
9.2.4.1 Increasing population of sheep and goats to drive growth in this segment
TABLE 47 ANTIMICROBIALS AND ANTIBIOTICS MARKET FOR SHEEP AND GOATS, BY COUNTRY, 2019–2026 (USD MILLION)
9.2.5 OTHER FOOD-PRODUCING ANIMALS
FIGURE 40 PER CAPITA FISH CONSUMPTION, 2019 VS. 2029
TABLE 48 ANTIMICROBIALS AND ANTIBIOTICS MARKET FOR OTHER FOOD-PRODUCING ANIMALS, BY COUNTRY, 2019–2026 (USD MILLION)
9.3 COMPANION ANIMALS
TABLE 49 ANTIMICROBIALS AND ANTIBIOTICS MARKET FOR COMPANION ANIMALS, BY TYPE, 2019–2026 (USD MILLION)
TABLE 50 ANTIMICROBIALS AND ANTIBIOTICS MARKET FOR COMPANION ANIMALS, BY COUNTRY, 2019–2026 (USD MILLION)
9.3.1 DOGS
9.3.1.1 Growing adoption of dogs to drive growth in this market segment
FIGURE 41 GROWING POPULATION OF PET DOGS IN INDIA (MILLION)
FIGURE 42 POPULATION OF PET DOGS GLOBALLY (MILLION)
TABLE 51 ANTIMICROBIALS AND ANTIBIOTICS MARKET FOR DOGS, BY COUNTRY, 2019–2026 (USD MILLION)
9.3.2 CATS
9.3.2.1 Growing research on feline health and wellbeing to support the market growth
TABLE 52 ANTIMICROBIALS AND ANTIBIOTICS MARKET FOR CATS, BY COUNTRY, 2019–2026 (USD MILLION)
9.3.3 HORSES
9.3.3.1 Declining horse population necessitates the adoption of health products—a key factor driving market growth
TABLE 53 ANTIMICROBIALS AND ANTIBIOTICS MARKET FOR HORSES, BY COUNTRY, 2019–2026 (USD MILLION)
9.3.4 OTHER COMPANION ANIMALS
TABLE 54 ANTIMICROBIALS AND ANTIBIOTICS MARKET FOR OTHER COMPANION ANIMALS, BY COUNTRY, 2019–2026 (USD MILLION)
10 ANIMAL ANTIMICROBIALS AND ANTIBIOTICS MARKET, BY REGION
10.1 INTRODUCTION
TABLE 55 COMPANION ANIMAL AND FOOD-PRODUCING ANIMAL POPULATION, BY COUNTRY, 2020 (IN THOUSAND)
TABLE 56 ANIMAL ANTIMICROBIALS AND ANTIBIOTICS MARKET, BY REGION, 2019–2026 (USD MILLION)
10.2 NORTH AMERICA
FIGURE 43 EXPECTED GROWTH IN THE NUMBER OF VETERINARIANS IN NORTH AMERICA
FIGURE 44 NORTH AMERICA: ANIMAL ANTIMICROBIALS AND ANTIBIOTICS MARKET SNAPSHOT
TABLE 57 NORTH AMERICA: ANIMAL ANTIMICROBIALS AND ANTIBIOTICS MARKET, BY COUNTRY, 2019–2026 (USD MILLION)
TABLE 58 NORTH AMERICA: ANIMAL ANTIMICROBIALS AND ANTIBIOTICS MARKET, BY PRODUCT, 2019–2026 (USD MILLION)
TABLE 59 NORTH AMERICA: ANIMAL ANTIMICROBIALS AND ANTIBIOTICS MARKET, BY MODE OF DELIVERY, 2019–2026 (USD MILLION)
TABLE 60 NORTH AMERICA: ANIMAL ANTIMICROBIALS AND ANTIBIOTICS MARKET, BY TYPE OF ANIMAL, 2019–2026 (USD MILLION)
TABLE 61 NORTH AMERICA: ANIMAL ANTIMICROBIALS AND ANTIBIOTICS MARKET FOR FOOD-PRODUCING ANIMALS, BY TYPE, 2019–2026 (USD MILLION)
TABLE 62 NORTH AMERICA: ANIMAL ANTIMICROBIALS AND ANTIBIOTICS MARKET FOR COMPANION ANIMALS, BY TYPE, 2019–2026 (USD MILLION)
10.2.1 US
10.2.1.1 Rising pet expenditure and increasing meat consumption are driving the market in the US
FIGURE 45 US: GROWTH IN BEEF CONSUMPTION, 2014–2019 (BILLION POUNDS)
FIGURE 46 US: INCREASE IN PET EXPENDITURE, 2010–2019 (USD BILLION)
FIGURE 47 DOMESTIC SALES AND DISTRIBUTION OF MEDICALLY IMPORTANT ANTIMICROBIAL DRUGS FOR PRODUCTION AND THERAPEUTIC INDICATIONS IN THE US (THOUSAND KG)
TABLE 63 US: PRIVATE CLINICAL PRACTICES, BY ANIMAL TYPE, 2016 VS. 2018
TABLE 64 US: ANIMAL ANTIMICROBIALS AND ANTIBIOTICS MARKET, BY PRODUCT, 2019–2026 (USD MILLION)
TABLE 65 US: ANIMAL ANTIMICROBIALS AND ANTIBIOTICS MARKET, BY MODE OF DELIVERY, 2019–2026 (USD MILLION)
TABLE 66 US: ANIMAL ANTIMICROBIALS AND ANTIBIOTICS MARKET, BY TYPE OF ANIMAL, 2019–2026 (USD MILLION)
TABLE 67 US: ANIMAL ANTIMICROBIALS AND ANTIBIOTICS MARKET FOR FOOD-PRODUCING ANIMALS, BY TYPE, 2019–2026 (USD MILLION)
TABLE 68 US: ANIMAL ANTIMICROBIALS AND ANTIBIOTICS MARKET FOR COMPANION ANIMALS, BY TYPE, 2019–2026 (USD MILLION)
10.2.2 CANADA
10.2.2.1 Growing pet adoption rate to drive the market in Canada
TABLE 69 CANADA: ANIMAL ANTIMICROBIALS AND ANTIBIOTICS MARKET, BY PRODUCT, 2019–2026 (USD MILLION)
TABLE 70 CANADA: ANIMAL ANTIMICROBIALS AND ANTIBIOTICS MARKET, BY MODE OF DELIVERY, 2019–2026 (USD MILLION)
TABLE 71 CANADA: ANIMAL ANTIMICROBIALS AND ANTIBIOTICS MARKET, BY TYPE OF ANIMAL, 2019–2026 (USD MILLION)
TABLE 72 CANADA: ANIMAL ANTIMICROBIALS AND ANTIBIOTICS MARKET FOR FOOD-PRODUCING ANIMALS, BY TYPE, 2019–2026 (USD MILLION)
TABLE 73 CANADA: ANIMAL ANTIMICROBIALS AND ANTIBIOTICS MARKET FOR COMPANION ANIMALS, BY TYPE, 2019–2026 (USD MILLION)
10.3 EUROPE
TABLE 74 EUROPE: LIVESTOCK POPULATION, BY ANIMAL, 2011–2018 (MILLION HEAD)
TABLE 75 EUROPE: ANIMAL ANTIMICROBIALS AND ANTIBIOTICS MARKET, BY COUNTRY, 2019–2026 (USD MILLION)
TABLE 76 EUROPE: ANIMAL ANTIMICROBIALS AND ANTIBIOTICS MARKET, BY PRODUCT, 2019–2026 (USD MILLION)
TABLE 77 EUROPE: ANIMAL ANTIMICROBIALS AND ANTIBIOTICS MARKET, BY MODE OF DELIVERY, 2019–2026 (USD MILLION)
TABLE 78 EUROPE: ANIMAL ANTIMICROBIALS AND ANTIBIOTICS MARKET, BY TYPE OF ANIMAL, 2019–2026 (USD MILLION)
TABLE 79 EUROPE: ANIMAL ANTIMICROBIALS AND ANTIBIOTICS MARKET FOR FOOD-PRODUCING ANIMALS, BY TYPE, 2019–2026 (USD MILLION)
TABLE 80 EUROPE: ANIMAL ANTIMICROBIALS AND ANTIBIOTICS MARKET FOR COMPANION ANIMALS, BY TYPE, 2019–2026 (USD MILLION)
10.3.1 SPAIN
10.3.1.1 Large volume of sales of important antibiotics in this country to drive market growth
TABLE 81 SPAIN: LARGE ANIMAL POPULATION, 2001–2019 (MILLION)
TABLE 82 SPAIN: ANIMAL ANTIMICROBIALS AND ANTIBIOTICS MARKET, BY PRODUCT, 2019–2026 (USD MILLION)
TABLE 83 SPAIN: ANIMAL ANTIMICROBIALS AND ANTIBIOTICS MARKET, BY MODE OF DELIVERY, 2019–2026 (USD MILLION)
TABLE 84 SPAIN: ANIMAL ANTIMICROBIALS AND ANTIBIOTICS MARKET, BY TYPE OF ANIMAL, 2019–2026 (USD MILLION)
TABLE 85 SPAIN: ANIMAL ANTIMICROBIALS AND ANTIBIOTICS MARKET FOR FOOD-PRODUCING ANIMALS, BY TYPE, 2019–2026 (USD MILLION)
TABLE 86 SPAIN: ANIMAL ANTIMICROBIALS AND ANTIBIOTICS MARKET FOR COMPANION ANIMALS, BY TYPE, 2019–2026 (USD MILLION)
10.3.2 ITALY
10.3.2.1 Need to curb zoonotic diseases in livestock will contribute to the demand for animal antimicrobials and antibiotics market in Italy
TABLE 87 ITALY: ANIMAL ANTIMICROBIALS AND ANTIBIOTICS MARKET, BY PRODUCT, 2019–2026 (USD MILLION)
TABLE 88 ITALY: ANIMAL ANTIMICROBIALS AND ANTIBIOTICS MARKET, BY MODE OF DELIVERY, 2019–2026 (USD MILLION)
TABLE 89 ITALY: ANIMAL ANTIMICROBIALS AND ANTIBIOTICS MARKET, BY TYPE OF ANIMAL, 2019–2026 (USD MILLION)
TABLE 90 ITALY: ANIMAL ANTIMICROBIALS AND ANTIBIOTICS MARKET FOR FOOD-PRODUCING ANIMALS, BY TYPE, 2019–2026 (USD MILLION)
TABLE 91 ITALY: ANIMAL ANTIMICROBIALS AND ANTIBIOTICS MARKET FOR COMPANION ANIMALS, BY TYPE, 2019–2026 (USD MILLION)
10.3.3 GERMANY
10.3.3.1 Increasing number of pets, increasing veterinary visits, and growing healthcare expenditure to boost the growth of the animal antimicrobials and antibiotics market in Germany
TABLE 92 GERMANY: COMPANION ANIMAL POPULATION, 2012–2018 (MILLION)
FIGURE 48 SALES SURVEILLANCE OF ANTIMICROBIALS FOR VETERINARY USE IN GERMANY (2011 TO 2018)
TABLE 93 GERMANY: ANIMAL ANTIMICROBIALS AND ANTIBIOTICS MARKET, BY PRODUCT, 2019–2026 (USD MILLION)
TABLE 94 GERMANY: ANIMAL ANTIMICROBIALS AND ANTIBIOTICS MARKET, BY MODE OF DELIVERY, 2019–2026 (USD MILLION)
TABLE 95 GERMANY: ANIMAL ANTIMICROBIALS AND ANTIBIOTICS MARKET, BY TYPE OF ANIMAL, 2019–2026 (USD MILLION)
TABLE 96 GERMANY: ANIMAL ANTIMICROBIALS AND ANTIBIOTICS MARKET FOR FOOD-PRODUCING ANIMALS, BY TYPE, 2019–2026 (USD MILLION)
TABLE 97 GERMANY: ANIMAL ANTIMICROBIALS AND ANTIBIOTICS MARKET FOR COMPANION ANIMALS, BY TYPE, 2019–2026 (USD MILLION)
10.3.4 FRANCE
10.3.4.1 Presence of major players has ensured the strong share of France in the overall market
TABLE 98 FRANCE: ANIMAL ANTIMICROBIALS AND ANTIBIOTICS MARKET, BY PRODUCT, 2019–2026 (USD MILLION)
TABLE 99 FRANCE: ANIMAL ANTIMICROBIALS AND ANTIBIOTICS MARKET, BY MODE OF DELIVERY, 2019–2026 (USD MILLION)
TABLE 100 FRANCE: ANIMAL ANTIMICROBIALS AND ANTIBIOTICS MARKET, BY TYPE OF ANIMAL, 2019–2026 (USD MILLION)
TABLE 101 FRANCE: ANIMAL ANTIMICROBIALS AND ANTIBIOTICS MARKET FOR FOOD-PRODUCING ANIMALS, BY TYPE, 2019–2026 (USD MILLION)
TABLE 102 FRANCE: ANIMAL ANTIMICROBIALS AND ANTIBIOTICS MARKET FOR COMPANION ANIMALS, BY TYPE, 2019–2026 (USD MILLION)
10.3.5 UK
10.3.5.1 Increasing pet ownership is expected to drive market growth
FIGURE 49 SALES OF ANTIBIOTICS FOR FOOD-PRODUCING ANIMALS IN THE UK FROM 2015 TO 2019 (MG/KG)
TABLE 103 UK: ANIMAL ANTIMICROBIALS AND ANTIBIOTICS MARKET, BY PRODUCT, 2019–2026 (USD MILLION)
TABLE 104 UK: ANIMAL ANTIMICROBIALS AND ANTIBIOTICS MARKET, BY MODE OF DELIVERY, 2019–2026 (USD MILLION)
TABLE 105 UK: ANIMAL ANTIMICROBIALS AND ANTIBIOTICS MARKET, BY TYPE OF ANIMAL, 2019–2026 (USD MILLION)
TABLE 106 UK: ANIMAL ANTIMICROBIALS AND ANTIBIOTICS MARKET FOR FOOD-PRODUCING ANIMALS, BY TYPE, 2019–2026 (USD MILLION)
TABLE 107 UK: ANIMAL ANTIMICROBIALS AND ANTIBIOTICS MARKET FOR COMPANION ANIMALS, BY TYPE, 2019–2026 (USD MILLION)
10.3.6 REST OF EUROPE
TABLE 108 ROE: ANIMAL ANTIMICROBIALS AND ANTIBIOTICS MARKET, BY PRODUCT, 2019–2026 (USD MILLION)
TABLE 109 ROE: ANIMAL ANTIMICROBIALS AND ANTIBIOTICS MARKET, BY MODE OF DELIVERY, 2019–2026 (USD MILLION)
TABLE 110 ROE: ANIMAL ANTIMICROBIALS AND ANTIBIOTICS MARKET, BY TYPE OF ANIMAL, 2019–2026 (USD MILLION)
TABLE 111 ROE: ANIMAL ANTIMICROBIALS AND ANTIBIOTICS MARKET FOR FOOD-PRODUCING ANIMALS, BY TYPE, 2019–2026 (USD MILLION)
TABLE 112 ROE: ANIMAL ANTIMICROBIALS AND ANTIBIOTICS MARKET FOR COMPANION ANIMALS, BY TYPE, 2019–2026 (USD MILLION)
10.4 ASIA PACIFIC (APAC)
TABLE 113 ASIA PACIFIC: FOOD-PRODUCING ANIMAL POPULATION, 2010–2017 (MILLION)
FIGURE 50 ASIA PACIFIC: ANIMAL ANTIMICROBIALS AND ANTIBIOTICS MARKET SNAPSHOT
TABLE 114 ASIA PACIFIC: ANIMAL ANTIMICROBIALS AND ANTIBIOTICS MARKET, BY COUNTRY, 2019–2026 (USD MILLION)
TABLE 115 ASIA PACIFIC: ANIMAL ANTIMICROBIALS AND ANTIBIOTICS MARKET, BY PRODUCT, 2019–2026 (USD MILLION)
TABLE 116 ASIA PACIFIC: ANIMAL ANTIMICROBIALS AND ANTIBIOTICS MARKET, BY MODE OF DELIVERY, 2019–2026 (USD MILLION)
TABLE 117 ASIA PACIFIC: ANIMAL ANTIMICROBIALS AND ANTIBIOTICS MARKET, BY TYPE OF ANIMAL, 2019–2026 (USD MILLION)
TABLE 118 ASIA PACIFIC: ANIMAL ANTIMICROBIALS AND ANTIBIOTICS MARKET FOR FOOD-PRODUCING ANIMALS, BY TYPE, 2019–2026 (USD MILLION)
TABLE 119 ASIA PACIFIC: ANIMAL ANTIMICROBIALS AND ANTIBIOTICS MARKET FOR COMPANION ANIMALS, BY TYPE, 2019–2026 (USD MILLION)
10.4.1 CHINA
10.4.1.1 China dominates the APAC animal antimicrobials and antibiotics market
TABLE 120 CHINA: FOOD-PRODUCING ANIMAL POPULATION, 2012–2019 (MILLION)
TABLE 121 CHINA: ANIMAL ANTIMICROBIALS AND ANTIBIOTICS MARKET, BY PRODUCT, 2019–2026 (USD MILLION)
TABLE 122 CHINA: ANIMAL ANTIMICROBIALS AND ANTIBIOTICS MARKET, BY MODE OF DELIVERY, 2019–2026 (USD MILLION)
TABLE 123 CHINA: ANIMAL ANTIMICROBIALS AND ANTIBIOTICS MARKET, BY TYPE OF ANIMAL, 2019–2026 (USD MILLION)
TABLE 124 CHINA: ANIMAL ANTIMICROBIALS AND ANTIBIOTICS MARKET FOR FOOD-PRODUCING ANIMALS, BY TYPE, 2019–2026 (USD MILLION)
TABLE 125 CHINA: ANIMAL ANTIMICROBIALS AND ANTIBIOTICS MARKET FOR COMPANION ANIMALS, BY TYPE, 2019–2026 (USD MILLION)
10.4.2 JAPAN
10.4.2.1 Rising demand for imported breeds is driving pet adoption in the country
TABLE 126 PRODUCTION AND CONSUMPTION OF ANIMAL-DERIVED FOOD PRODUCTS
IN JAPAN (2000 VS. 2030) (THOUSAND METRIC TONS)
FIGURE 51 VOLUMES OF VETERINARY ANTIMICROBIALS SOLD BY PHARMACEUTICAL COMPANIES IN JAPAN, 2001–2017 (IN TONS OF ACTIVE INGREDIENT)
FIGURE 52 AMOUNT OF ANTIMICROBIAL FEED ADDITIVES MANUFACTURED IN JAPAN, 2003–2017 (IN TONS OF ACTIVE INGREDIENT)
TABLE 127 JAPAN: ANIMAL ANTIMICROBIALS AND ANTIBIOTICS MARKET, BY PRODUCT, 2019–2026 (USD MILLION)
TABLE 128 JAPAN: ANIMAL ANTIMICROBIALS AND ANTIBIOTICS MARKET, BY MODE OF DELIVERY, 2019–2026 (USD MILLION)
TABLE 129 JAPAN: ANIMAL ANTIMICROBIALS AND ANTIBIOTICS MARKET, BY TYPE OF ANIMAL, 2019–2026 (USD MILLION)
TABLE 130 JAPAN: ANIMAL ANTIMICROBIALS AND ANTIBIOTICS MARKET FOR FOOD-PRODUCING ANIMALS, BY TYPE, 2019–2026 (USD MILLION)
TABLE 131 JAPAN: ANIMAL ANTIMICROBIALS AND ANTIBIOTICS MARKET FOR COMPANION ANIMALS, BY TYPE, 2019–2026 (USD MILLION)
10.4.3 INDIA
10.4.3.1 Rising food-producing animal population and growing awareness about animal health will contribute to market growth during the forecast period
TABLE 132 PRODUCTION AND CONSUMPTION OF ANIMAL-DERIVED FOOD PRODUCTS IN INDIA (2000 VS. 2030) (THOUSAND METRIC TONS)
TABLE 133 INDIA: ANIMAL ANTIMICROBIALS AND ANTIBIOTICS MARKET, BY PRODUCT, 2019–2026 (USD MILLION)
TABLE 134 INDIA: ANIMAL ANTIMICROBIALS AND ANTIBIOTICS MARKET, BY MODE OF DELIVERY, 2019–2026 (USD MILLION)
TABLE 135 INDIA: ANIMAL ANTIMICROBIALS AND ANTIBIOTICS MARKET, BY TYPE OF ANIMAL, 2019–2026 (USD MILLION)
TABLE 136 INDIA: ANIMAL ANTIMICROBIALS AND ANTIBIOTICS MARKET FOR FOOD-PRODUCING ANIMALS, BY TYPE, 2019–2026 (USD MILLION)
TABLE 137 INDIA: ANIMAL ANTIMICROBIALS AND ANTIBIOTICS MARKET FOR COMPANION ANIMALS, BY TYPE, 2019–2026 (USD MILLION)
10.4.4 REST OF ASIA PACIFIC (REST OF APAC)
TABLE 138 REGULATORY SCENARIO FOR ANTIBIOTICS IN THE ROAPAC, BY COUNTRY
TABLE 139 REST OF APAC: ANIMAL ANTIMICROBIALS AND ANTIBIOTICS MARKET, BY PRODUCT, 2019–2026 (USD MILLION)
TABLE 140 REST OF APAC: ANIMAL ANTIMICROBIALS AND ANTIBIOTICS MARKET, BY MODE OF DELIVERY, 2019–2026 (USD MILLION)
TABLE 141 REST OF APAC: ANIMAL ANTIMICROBIALS AND ANTIBIOTICS MARKET, BY TYPE OF ANIMAL, 2019–2026 (USD MILLION)
TABLE 142 REST OF APAC: ANIMAL ANTIMICROBIALS AND ANTIBIOTICS MARKET FOR FOOD-PRODUCING ANIMALS, BY TYPE, 2019–2026 (USD MILLION)
TABLE 143 REST OF APAC: ANIMAL ANTIMICROBIALS AND ANTIBIOTICS MARKET FOR COMPANION ANIMALS, BY TYPE, 2019–2026 (USD MILLION)
10.5 LATIN AMERICA
TABLE 144 LATIN AMERICA: FOOD-PRODUCING ANIMALS POPULATION, BY COUNTRY (2010–2014) (MILLION)
TABLE 145 LATIN AMERICA: ANIMAL ANTIMICROBIALS AND ANTIBIOTICS MARKET, BY PRODUCT, 2019–2026 (USD MILLION)
TABLE 146 LATIN AMERICA: ANIMAL ANTIMICROBIALS AND ANTIBIOTICS MARKET, BY MODE OF DELIVERY, 2019–2026 (USD MILLION)
TABLE 147 LATIN AMERICA: ANIMAL ANTIMICROBIALS AND ANTIBIOTICS MARKET, BY TYPE OF ANIMAL, 2019–2026 (USD MILLION)
TABLE 148 LATIN AMERICA: ANIMAL ANTIMICROBIALS AND ANTIBIOTICS MARKET FOR FOOD-PRODUCING ANIMALS, BY TYPE, 2019–2026 (USD MILLION)
TABLE 149 LATIN AMERICA: ANIMAL ANTIMICROBIALS AND ANTIBIOTICS MARKET FOR COMPANION ANIMALS, BY TYPE, 2019–2026 (USD MILLION)
10.6 MIDDLE EAST & AFRICA
TABLE 150 AFRICA: NUMBER OF VETERINARIANS, 2010 VS. 2014 VS. 2016
TABLE 151 MIDDLE EAST & AFRICA: ANIMAL ANTIMICROBIALS AND ANTIBIOTICS MARKET, BY PRODUCT, 2019–2026 (USD MILLION)
TABLE 152 MIDDLE EAST & AFRICA: ANIMAL ANTIMICROBIALS AND ANTIBIOTICS MARKET, BY MODE OF DELIVERY, 2019–2026 (USD MILLION)
TABLE 153 MIDDLE EAST & AFRICA: ANIMAL ANTIMICROBIALS AND ANTIBIOTICS MARKET, BY TYPE OF ANIMAL, 2019–2026 (USD MILLION)
TABLE 154 MIDDLE EAST & AFRICA: ANIMAL ANTIMICROBIALS AND ANTIBIOTICS MARKET FOR FOOD-PRODUCING ANIMALS, BY TYPE, 2019–2026 (USD MILLION)
TABLE 155 MIDDLE EAST & AFRICA: ANIMAL ANTIMICROBIALS AND ANTIBIOTICS MARKET FOR COMPANION ANIMALS, BY TYPE, 2019–2026 (USD MILLION)
11 COMPETITIVE LANDSCAPE
11.1 INTRODUCTION
FIGURE 53 KEY DEVELOPMENTS OF MAJOR PLAYERS BETWEEN 2017 AND JAN 2021
11.2 MARKET EVALUATION FRAMEWORK
FIGURE 54 MARKET EVALUATION FRAMEWORK: ACQUISITIONS—THE MOST WIDELY ADOPTED STRATEGY
11.3 PRODUCT PORTFOLIO MATRIX
TABLE 156 PLAYERS IN THE ANIMAL ANTIMICROBIALS AND ANTIBIOTICS MARKET: PRODUCT PORTFOLIO ANALYSIS
11.4 ANIMAL ANTIMICROBIALS AND ANTIBIOTICS MARKET: GEOGRAPHICAL ASSESSMENT
FIGURE 55 GEOGRAPHIC ASSESSMENT OF KEY PLAYERS IN THE ANIMAL ANTIMICROBIALS AND ANTIBIOTICS MARKET (2019)
11.5 ANIMAL ANTIMICROBIALS AND ANTIBIOTICS MARKET: R&D EXPENDITURE
FIGURE 56 R&D EXPENDITURE OF KEY PLAYERS IN THE ANIMAL ANTIMICROBIALS AND ANTIBIOTICS MARKET (2019)
11.6 REVENUE ANALYSIS: TOP 5 PLAYERS
FIGURE 57 ANIMAL ANTIMICROBIALS AND ANTIBIOTICS MARKET: REVENUE ANALYSIS (2019)
11.7 VENDOR DIVE
11.7.1 STARS
11.7.2 EMERGING LEADERS
11.7.3 PERVASIVE PLAYERS
11.7.4 EMERGING COMPANIES
FIGURE 58 COMPETITIVE LEADERSHIP MAPPING: ANIMAL ANTIMICROBIALS AND ANTIBIOTICS MARKET, 2020
11.8 MARKET SHARE ANALYSIS
TABLE 157 ANIMAL ANTIMICROBIALS AND ANTIBIOTICS MARKET: DEGREE OF COMPETITION
FIGURE 59 ANIMAL ANTIMICROBIALS AND ANTIBIOTICS MARKET SHARE ANALYSIS, BY KEY PLAYER, 2020
11.9 COMPETITIVE SITUATION AND TRENDS
11.9.1 PRODUCT LAUNCHES & APPROVALS
TABLE 158 PRODUCT LAUNCHES & APPROVALS
11.9.2 PARTNERSHIPS, AGREEMENTS, AND COLLABORATIONS
TABLE 159 PARTNERSHIPS, AGREEMENTS, AND COLLABORATIONS
11.9.3 MERGERS, ACQUISITIONS, AND DIVESTITURES
TABLE 160 MERGERS, ACQUISITIONS, AND DIVESTITURES
11.9.4 EXPANSIONS
TABLE 161 EXPANSIONS
11.10 SME MATRIX
11.10.1 COMPETITIVE LEADERSHIP MAPPING (SMES)
11.10.1.1 Progressive companies
11.10.1.2 Starting blocks
11.10.1.3 Responsive companies
11.10.1.4 Dynamic companies
FIGURE 60 ANIMAL ANTIMICROBIALS AND ANTIBIOTICS MARKET: COMPETITIVE LEADERSHIP MAPPING FOR SME, 2020
12 COMPETITIVE EVALUATION MATRIX AND COMPANY PROFILES
12.1 KEY PLAYERS
(Business overview, Products offered, Recent developments, MNM view)*
12.1.1 ZOETIS, INC.
TABLE 162 ZOETIS, INC.: BUSINESS OVERVIEW
FIGURE 61 ZOETIS: COMPANY SNAPSHOT (2019)
12.1.2 MERCK & CO., INC.
TABLE 163 MERCK AND CO., INC: BUSINESS OVERVIEW
FIGURE 62 MERCK & CO., INC.: COMPANY SNAPSHOT (2019)
12.1.3 BOEHRINGER INGELHEIM GMBH
TABLE 164 BOEHRINGER INGELHEIM GMBH: BUSINESS OVERVIEW
FIGURE 63 BOEHRINGER INGELHEIM GMBH: COMPANY SNAPSHOT (2019)
12.1.4 ELANCO ANIMAL HEALTH
TABLE 165 ELANCO ANIMAL HEALTH: BUSINESS OVERVIEW
FIGURE 64 ELANCO ANIMAL HEALTH: COMPANY SNAPSHOT (2019)
12.1.5 CEVA SANT? ANIMALE
TABLE 166 CEVA SANT? ANIMALE: BUSINESS OVERVIEW
12.1.6 VIRBAC
TABLE 167 VIRBAC: BUSINESS OVERVIEW
FIGURE 65 VIRBAC: COMPANY SNAPSHOT (2019)
12.1.7 VETOQUINOL SA.
TABLE 168 VETOQUINOL S.A.: BUSINESS OVERVIEW
FIGURE 66 VETOQUINOL SA: COMPANY SNAPSHOT (2019)
12.1.8 DECHRA PHARMACEUTICALS PLC
TABLE 169 DECHRA PHARMACEUTICALS PLC: BUSINESS OVERVIEW
FIGURE 67 DECHRA PHARMACEUTICALS PLC: COMPANY SNAPSHOT (2019)
12.1.9 PHIBRO ANIMAL HEALTH
TABLE 170 PHIBRO ANIMAL HEALTH: BUSINESS OVERVIEW
FIGURE 68 PHIBRO ANIMAL HEALTH: COMPANY SNAPSHOT (2019)
12.1.10 KYORITSU SEIYAKU
TABLE 171 KYORITSU SEIYAKU: BUSINESS OVERVIEW
12.1.11 ZYDUS ANIMAL HEALTH
TABLE 172 ZYDUS ANIMAL HEALTH: BUSINESS OVERVIEW
FIGURE 69 ZYDUS: COMPANY SNAPSHOT (2019)
12.1.12 TIANJIN RINGPU
TABLE 173 TIANJIN RINGPU: BUSINESS OVERVIEW
12.1.13 HIPRA
TABLE 174 HIPRA: BUSINESS OVERVIEW
12.1.14 CHINA ANIMAL HUSBANDRY
TABLE 175 CHINA ANIMAL HUSBANDRY: BUSINESS OVERVIEW
12.1.15 INOVET
TABLE 176 INOVET: BUSINESS OVERVIEW
*Business overview, Products offered, Recent developments, MNM view might not be captured in case of unlisted companies.
12.2 OTHER EMERGING COMPANIES
12.2.1 ENDOVAC ANIMAL HEALTH
12.2.2 ECO ANIMAL HEALTH GROUP PLC
12.2.3 INDIAN IMMUNOLOGICALS LTD.
12.2.4 ASHISH LIFE SCIENCE (ALS)
12.2.5 LUTIM PHARMA
13 APPENDIX
13.1 DISCUSSION GUIDE
13.2 KNOWLEDGE STORE: MARKETSANDMARKETS’ SUBSCRIPTION PORTAL
13.3 AVAILABLE CUSTOMIZATIONS
13.4 RELATED REPORTS
13.5 AUTHOR DETAILS
